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ABSTRACT
The enzyme collagenase is involved in degrading uterine collagen during postpartum
involution. It has been reported that cultures of rat and human myometrial smooth
muscle cells produce collagenase when grown in medium containing fetal bovine serum
(FBS) but not in medium containing newborn bovine serum (NBS). The substance in
FBS that induces the cells to produce collagenase is 5-hydroxytryptamine (5-HT,
serotonin). The concentration of 5-HT in FBS is between 30 µM-50 µM. In contrast,
NBS has a concentration of approximately 1 µM or less . It has been proposed that 5HT serves as a signal to initiate uterine collagen hydrolysis. Furthermore, a 5-HT
transporter exists in the mouse and human placenta. The function of the transporter is
not known, however it is speculated that it may act in growth and development of the
fetus. Five-HT is known to act as a growth factor for many cell types yet its effect on
placental cells is not known. In addition, the source of 5-HT found in placental tissue is
unclear. It may be that the source for placental 5-HT is the fetal intestine since 95% of
the body' s 5-HT is located in the gastrointestinal tract and intestinal resection causes a
drop in blood concentration of 5-HT.
The working hypothesis of this research was that 5-HT from the fetal intestine is a
"proliferation factor" that supports placental cell growth and inhibits activity of matrix
metalloproteinases (MMPs) during pregnancy. It is suspected that withdrawal of fetal 5HT during partum causes placenta separation by cessation of cell proliferation and
stimulation ofMMP secretion. The objectives of this research were to : determine 5-HT
concentrations in blood and tissues of bovine fetuses and neonates; determine whether or
not 5-HT acts as a proliferation factor for cultured placental cells; determine whether 5HT stimulates or inhibits placental MMP activity in cultured cell s, isolated placentomes,
and pregnant cows; and immunolocalize 5-HT and collagenase in placental tissue.
Blood, intestine, cotyledon, caruncle, and muscle were collected from mid-term and
V

full-term gestation fetuses at an abattoir and from 24 hour and 48-72 hour old calves
obtained from The University of Tennessee Dairy Farm. Blood was collected from the
umbilical cord of cesarean section fetuses and from pregnant and non-pregnant cows.
Samples were analyzed using an enzyme immunoassay procedure. Fetal blood 5-HT
concentrations remained elevated from mid (54, 111 nM) through full (51 ,640 nM)
pregnancy, declined (P

0.05) during delivery (13,625 nM), and stayed low in 24 hour

old calves (24,460 nM), 48-72 hour old calves (18,400 nM), and in cows (8,004 nM) .
Five-HT concentration in intestine of mid (5,321 ng/g) and full (7,059 ng/g) gestation
fetuses and 48-72 hour old calves (6,618 ng/g) was significantly higher (P

0.05) than

24 hour old calves (1 ,410 ng/g) and cows (3 ,049 ng/g) . Concentration of 5-HT in
placenta of mid (4,570 ng/g) and full (5 ,788 ng/g) gestation fetuses was significantly
higher (P

0.05) than postpartum placenta (1 ,176 ng/g) . Concentration of5-HT in

muscle of mid gestation fetuses (1 ,412 ng/g) and 24 hour old calf (1,759 ng/g) were
significantly lower (P

0.05) than in full gestation fetuses (4,941 ng/g).

Cotyledon and caruncle cells were cultured from primary explants of cow placenta.
Ten thousand cells were plated in each well of a 96-well plate. Cells were either used as
control or treated with 5-HT ranging in concentration from 2.5 µM to 10 µM. The
proliferative effect of 5-HT was determined by incorporation of 3H-thymidine into DNA
of cells, a tetrazolium-based colorimetric proliferation assay, and cell count. Increasing
concentrations of 5-HT were shown to stimulate incorporation of 3H-thymidine into
DNA of cells; however, 5-HT was inhibitory of the reaction in the colorimetric
proliferation assay. Five-HT had no effect on cell number when counted on a
hemacytometer or by a Coulter counter.
Cultured cotyledon and caruncle cells were grown in serum-free medium, and
medium supplemented with either FBS or 1\TBS and stimulated with 5 µM 5-HT. Media
samples were analyzed for

:tv1M})

activity using a fluorometric technique. Five-HT did
vi

not stimulate M11P activity; however, when all 5-HT samples were pooled (2.05 nM),
there was significant (P

0.05) inhibition ofM11P activity compared to control (3 .81

nM) . Isolated placentomes were: (1) perfused for 4 hours with blood containing 50 µM
5-HT then incubated for 4 hours with 5-HT, and (2) infused with 5 µM 5-HT and
incubated for 4 hours to 11 hours. Matrix metalloproteinase activity was determined
using a manometric technique and hydroxyproline and total protein analysis. There were
no differences (P;?: 0.05) in manometric pressure (force needed to separate cotyledon
from caruncle) between control (118 mm Hg) and 5-HT (116 mm Hg) treated
placentomes nor in the amount of total protein released in control (1.70 mg/dL) and 5HT (1.61 mg/dL) treated placentomes. However, amount of hydroxyproline released
was discretely higher (P

0.05) from 5-HT (2.06 µg/mL) treated placentomes than from

controls (1.57 µg/mL). Fourteen near-term cows were induced to deliver with injections
of dexamethasone and PGF2a. These injections also cause approximately 70% of cows
to retain their placenta. Twenty-four hours later, 7 cows were injected with 50 µg/kg of
5-HT and 7 cows were injected with saline every 12 hours until delivery or for a total of
3 days. In each group, all but 1 cow retained placenta. Results of these experiments
indicated that 5-HT does not stimulate M11P activity in the induced model.
Cotyledons and caruncles from mid and full gestation and naturally delivered
placentae were fi xed for light microscopy and electron microscopy study. Using light
microscopy, 5-HT was localized to the surface membrane of epithelial cells and
connective tissue of prepartum cotyledons and caruncles and postpartum cotyledons.
Using electron microscopy, 5-HT was localized in close proximity to collagen fibers of
postpartum cotyledons. We were unable to localize collagenase in the bovine placenta.
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The results of this research support the following : (1) a pattern of 5-HT
concentration change during pregnancy and parturition; (2) 5-HT may be a proliferation
factor for placenta; (3) 5-HT did not stimulate l\1MP activity in placenta; (4) 5-HT is
present in the bovine placenta during pregnancy and postpartum.
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PARTI
INTRODUCTION

1

STATEMENT OF PURPOSE

Justification
Fetal membrane rupture and placenta detachment are critical issues for physiological
termination of pregnancy. Placental detachment is proposed to be part of uterine
involution and can be considered as one of the earliest expressions of uterine involution.
Placenta detachment implies a gradual turn off of physiological interactions and
separation of anatomical connection between the fetus and the mother. In the cow,
placenta detachment is usually completed within 3 to 6 hours after the calf has been
expelled, which is contrary to most domesticated species including humans which expel
their placenta at delivery or shortly thereafter. The reason for physiological retention in
the cow is not known .
Fetal membrane rupture, placenta detachment and uterine involution are essential in
order to deliver the fetus and return the cow to fertile life. The basic mechanism of the
process of rupture, detachment and involution is activation of uterine-placental
proteolytic enzymes known as matrix metalloproteinases (l\1JvfPs). The best studied
l\1JvfP is collagenase. Activity of collagenase increases markedly during the peripartum
period in the cervix and in the early postpartum period in the uterus . The hydrolytic
capability of collagenase on placental tissues of the cow, mare and woman was
investigated in our laboratory. Our research led to the development of a specific
treatment for retained placenta based on the injection of collagenase into retained
placenta via the umbilical cord . Incidence of pathological retention (over 12 hours) is a
frequent occurrence in the cow. In this country, the average incidence of placental
retention in cows is 7% . Often retention may last between 2 and 10 days, impacting the
dairy industry with significant economic losses .
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Etiology of placental retention has been related to a lack of :M:MP activity during
partum. Factors regulating production and activation of collagenase in the uterus have
not been fully elucidated. It has been reported that gonadal steroids, relaxin, and
selected growth factors have a role in regulating collagenase. Most recently, 5hydroxytryptamine (5-HT, serotonin) present in fetal blood in high concentrations (3050-fold maternal blood) was found to induce collagenase production/activation by
cultured rat and human myometrial smooth muscle cells. Moreover, 5-HT is a
proliferation factor in many tissues and neoplasias. The above information suggested the
possibility that 5-HT may be involved in the control of activation of :M:MPs and/or
proliferation of placental cells. If 5-HT is a collagenase secretagogue and proliferation
factor, it may participate in placenta detachment and uterine involution . From a practical
perspective, injections of 5-HT may be useful in the treatment and prevention of retained
placenta by inducing uterine collagenase. On the other hand, if 5-HT is a placenta
proliferation factor, it may in part control placental growth and placental attachment
during pregnancy. With these ideas in mind, experiments were designed to attempt to
answer selected aspects of our working hypothesis . We hypothesize that high fetal blood
5-HT concentration may originate from the bovine fetal intestine and act as a
" proliferation factor ' to support placental cell growth during pregnancy. Partial
withdrawal (by decreased secretion and/or increased inactivation) of fetal blood 5-HT
may be a cause for both (I) arrest of placental cell proliferation and (2) inactivation of
:M:MPs. Activation of MMPs and arrest of placental cell proliferation would lead to
postpartum placenta detachment .
Objectives
The objectives of this research were:
I)

Determine concentration profile of 5-HT in intestine, placenta, muscle and

blood of bovine fetuses at different times during gestation and delivery, and in calves up
3

to 72 hours old.
2)

Assess growth stimulatory effect of 5-HT on bovine placental cells by direct cell

count, incorporation of 3H-thymidine into DNA, and a tetrazolium-based colorimetric
proliferation assay.
3)

Determine effect of 5-HT on M11P activity in bovine placental cells in culture,

in isolated placentomes, and in the whole animal.
4)

Localize 5-HT and collagenase in bovine placenta.

LITERATURE REVIEW
History of 5-HT
Serotonin, a low molecular weight (176 dalton) biogenic amine, was first known to
mammalian physiologists as a vasoconstrictor that appeared in serum when blood was
allowed to clot. It was considered a nuisance in perfusion experiments in which
defibrinated blood was used and was later considered to play a part in arterial
hypertension. This vasoconstrictor was finally isolated in 1948 and given the name
serotonin. A year later serotonin ' s acti ve moiety was identified as 5-hydroxytryptamine
(5-HT) . Further research in the 1950' s led to the discovery that serotonin was also
located in the gastric mucosa and in the brain (Goodman and Gilman, 1975). Today it is
known that serotonin is widely distributed in the animal and plant kingdoms, present in
vertebrates to fruits and nuts (Sanders-Bush and Mayer, 1996).
Biosynthesis of 5-HT
The chemical structure of 5-HT is : 3-(/3-aminoethyl)-5-hydroxyindole (Figure 1. 1).
Five-HT is synthesized from the essential amino acid tryptophan (Figure 1.2).
Approximately 2% of dietary tryptophan is converted to 5-HT. Tryptophan is
hydroxylated by the enzyme tryptophan-5-hydroxylase to 5-hydroxytryptophan (5-HTP),
then decarboxylated by the enzyme aromatic L-amino acid decarboxylase to
4
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Figure 1.1. Chemical structure of 5-HT.
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Figure 1.2. Biosynthetic pathway of 5-HT.
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5-hydroxytryptamine. The rate-limiting enzyme in 5-HT synthesis is tryptophan-5hydroxylase (Goodman and Gilman, 1975).
Metabolism of 5-HT
Five-HT is principally metabolized by monoamine oxidase (MAO) . Monoamine
oxidase is localized in mitochondria and has two isoforms, A and B. Monoamine
oxidase-A preferentially metabolizes 5-HT and norepinephrine, whereas MAO-B
preferentially metabolizes ~-phenylethylamine and benzylamine. Monoamine oxidase
deaminates 5-HT to form 5-hydroxyindole-acetaldehyde which is degraded to the main
metabolite 5-hydroxyindoleacetic acid (5-HIAA) by the enzyme aldehyde
dehydrogenase. Five-HT is also degraded to the minor metabolite 5-hydroxytryptophol
(5-HTOL) by the enzyme aldehyde reductase (Sanders-Bush and Mayer, 1996) (Figure
1.3).
Many tissues have the enzymes to metabolize 5-HT, however the main tissues that
degrade 5-HT are lung, liver, and brain. Following degradation, the principal metabolite
5-IDAA is excreted in the urine. Okatani et al. (1990) reported plasma free 5-IDAA
increased in pregnant women after 30 weeks of gestation and reached its peak at 37
weeks. In the fetus, 5-HIAA concentrations in umbilical cord plasma were found to be
significantly higher than in maternal plasma (Okatani et al. , 1990). This increase in fetal
5-IDAA appears to correspond with the increase in deaminating activity of MAO in the
placenta near the end of pregnancy (Kirkel et al. , 1992) and in fetal tissues (Benedetti et
al. , 1992). The half-life of 5-HT varies according to tissue and species. In rabbit, halflife of the following tissues were determined using

14

C-tryptophan and

14

C-

hydroxytryptophan : intestine, 11 hours; stomach, 17 hours; platelets and spleen, 33-48
hours; brain (determined by use of harmaline, a monoamine oxidase inhibitor), minutes
(Udenfriend and Weissbach, 1958). Half-life of 5-HT in human gastrointestinal tract was
determined to be 7 to 12 hours and 6 to 8 hours in dogs. In the brain, half-life was
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found to be between 10 to 30 minutes (Garattini and Valzelli, 1965).
Distribution of 5-HT

In mammals, approximately 95% of 5-HT found in the body is located in the
enterochromaffin cells of the gastrointestinal mucosa (Tyce, 1990). The concentration
of 5-HT in different parts of the gastrointestinal tract varies according to species. For
example, in the mouse a higher concentration of 5-HT is found in the large intestine (3.1
µg) compared to the small intestine (1.6 µg). The development of the enterochromaffin
system begins early in gestation. Enterochromaffin cells appear in the 3 month old
bovine fetus (Totzauer, 1991), and an immunohistochemical study in human fetal
intestine showed 5-HT immunoreactivity as early as 8 weeks of gestation (Facer et al.,
1989). The appearance of enterochromaffin cells correlates with first gastrointestinal
movements that commence in the first third of gestation (Totzauer et al. , 1991).
Five-HT has also been located in placenta by immunohistochemical methods (Huang
et al. , 1998) and its concentration directly guantitated (Garattini and Valzelli, 1965;
Fecteau and Eiler, 1996) . In a preliminary study of bovine placenta, Fecteau and Eiler
(1997) measured concentrations of 5-HT in prepartum placenta at 3 .1 µgig and at 1.1
µgig in postpartum placenta. In human placenta, prepartum 5-HT concentration was
much lower at 0.13 µgig (Garattini and Valzelli , 1965) than bovine placenta. There is
disagreement, however, to whether or not the placenta can synthesize 5-HT. Huang et
al. (1998) stated that trophoblast cells cultured in serum-free medium and
syncytiotrophoblasts and stromal cells showed 5-HT immunoreactivity suggesting that
human placental villi may produce 5-HT. However, Yavarone et al. (1993) stated that
no evidence of 5-HT synthesis by the mouse placenta was found and that 5-HT present
in the placenta is due to uptake, not synthesis. It is interesting that no literature is
available concerning the enzyme tryptoph an hydroxylase in the placenta. In order for the
placenta to synthesize 5-HT, it must have the hydro xylase and decarboxylase enzymes.
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The purpose of 5-HT in the placenta is not known.
Five-HT can be found in a variety of other body tissues, in blood platelets and in
central nervous system (CNS) neurons. The role of platelet 5-HT is to promote platelet
aggregation and act as a constrictor at the site of blood vessel injury (Goodman and
Gilman, 1975). Platelets cannot synthesize their own 5-HT because they lack the
decarboxylase enzyme. Instead, platelets sequester 5-HT that is released into the blood
by enterochromaffin cells. Platelets take up 5-HT by passive diffusion and active
transport. In the cell, 5-HT is bound to ATP and divalent cations and stored in vesicles.
In the CNS, 5-HT acts as a neurotransmitter and influences sleep, appetite, and
temperature regulation as well as many other functions (Sanders-Bush and Mayer,
1996).
Pharmacological Actions of 5-HT
The actions of 5-HT are varied and often species dependent. For example,
administration of 5-HT caused renal vasoco nstriction in rabbits, however dogs
responded with an initial increase and later a decrease in renal blood flow (Hindle, 1994).
Not only are the actions of 5-HT species dependent, they are also receptor dependent. 5HT2 and 5-HT I receptors mediated the increase and decrease of dogs' renal blood flow,
respectively. Currently, there are 7 5-HT receptors (5-HT 1 to 5-HT7 ) (Peroutka, 1994;
Lucas and Hen, 1995) with more than 16 receptor subtypes ( ex. 5-HT2A) (Saxena,
1995). All 5-HT receptors belong to the G-protein superfamily, except the 5-HT 3
receptor which forms a part of cation channels (Saxena, 1995).
In the gastrointestinal tract, 5-HT can either stimulate or inhibit gastric and smooth
muscle motility and contraction depending on which receptor subtype is involved in the
action. Five-HT can facilitate gastrointestinal peristalsis by causing constriction of
smooth muscle through direct action on the muscle and by stimulating ganglion cells in
the intestinal wall (Burkhalter and Frick, 1984). Many studies demonstrated the
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involvement of 5-HT4 receptor in peristalsis (Foxx-Orenstein et al., 1998; Sanger et al.,
1998). In one study, 5-HT 4 agonists along with a delta-receptor antagonist increased the
velocity of propulsion in isolated colonic segments of guinea pig intestine (FoxxOrenstein, 1998). Sanger et al. (1998) studied the ability of a new 5-HT4 receptor
antagonist (SB-207266) to reduce the symptoms of irritable bowel syndrome. They used
human isolated intestine, guinea pig isolated ileum and conscio~s mice. The antagonist
did not affect normal patterns of intestinal motility however it did, in a concentrationdependent manner, antagonize the ability of 5-HT to sensitize the peristaltic reflex and
lower the distention threshold at which peristalsis was evoked .
Five-HT acts on smooth muscle elsewhere in the body. Five-HT, Substance P,
neuropeptide Y and VIP were localized by immunocytochemical staining methods in
mouse lung. There was widespread distribution of isolated endocrine cells and neuroepithelial bodies containing 5-HT-like immunoreactivity. Substance P immunoreactivity
was observed in nerve fibers located in smooth muscle of the airways . Neuropeptide Y
was visualized in nerve fibers in airway smooth muscle and surrounding the blood vessels
while VIP- like immunoreactivity was located in nerve fibers and ganglia around blood
vessels and in bronchial smooth muscle. It was suggested that these substances play a
role in the regulatory function of the mouse respiratory tract by endocrine, paracrine or
neurosecretory pathways or a combination of the three (Verastegui et al. , 1997).
Five-HT has been shown to have excitatory effects on upper airway motoneurons,
which is reduced during sleep. Veasey et al. (1996) studied the effects of two 5-HT
antagonists on upper airway dilator-muscle activity and diaphragm activity in an animal
model of sleep disordered breathing. The results showed reduced dilator muscle activity
and lesser reductions in diaphragm activity along with inspiratory collapse suggesting
that 5-HT is important in the maintenance of patent upper airways in obstructive sleep
apnea. Desmecht et al. ( 1992) observed various reversible adverse effects when 5-HT

(0.05 mg/kg) was administered to calves either intravenously (IV) or in bolus form.
Response to 5-HT consisted of bronchoconstriction, pulmonary vasoconstriction, and
congestion of conjunctiva, lacrimation, and tachypnea. In our own experience, injecting
cows with 5-HT at a dose of 50 µg/kg in bolus (IV) form caused an almost immediate
response of increased respiratory rate, defecation and lacrimation that was short-lived
(Fecteau and Eiler, unpublished). A lower 5-HT dose of 5 µg/kg did not elicit the same
response. In blood vessels, 5-HT can cause vasoconstriction or vasodilatation. In the
rat, rabbit and mouse, 5-HT caused placental, uterine and umbilical vessels to constrict,
and in some laboratory animals caused necrosis of the renal cortex due to the extreme
sensitivity of renal vessels to 5-HT. The vasodilatation effect of 5-HT occurs in vessels
of skeletal muscle as demonstrated by increased blood flow in areas such as calf and
forearm (Goodman and Gilman, 1975).
In the mammalian nervous system, 5-HT modulates numerous sensory, motor and
behavioral processes (Tecott et al., 1995). Tecott et al. (1995) generated mutant mice
lacking functional 5-HT 2c receptors that were proposed to mediate numerous central
nervous system actions of 5-HT. They found that the mutant mice were prone to
spontaneous death from seizures, suggesting that 5-HT 2c receptors mediate tonic
inhibition of neuronal network excitability. In addition, the mutant mice were twice as
heavy as their wild-type siblings. A non-selective serotonergic agonist with high affinity
for 5-HT2c receptors was administered to both mutants and wild type to act as an
appetite suppressant. Food intake was reduced in the wild-type mice but not in the
mutant mice, and it was determined that mice were not obese due to a metabolic
disorder. The mice were determined overweight as a result of abnormal control of
feeding behavior, establishing a role for 5-HT 2c receptor in serotonergic control of
appetite.
Five-HT is involved in neuroendocrine control and has been shown to facilitate the
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release of prolactin (PRL) and adrenocorticotropin releasing hormone (ACTH) and
under certain conditions inhibits release ofluteinizing hormone. Di Sciullo et al. (1990)
determined, using 8-Hydroxy-2-( di-n-propylamino )tetralin and ipsapirone, that 5-HT IA
receptors are involved in regulation of PRL, ACTH and ~-endorphin secretion.
However, ipsapirone behaved as a partial agonist on ACTH and ~-endorphin secretion
suggesting that different neuronal targets are involved in the stimulation of the three
hormones by 5-HT.
Reproduction and 5-HT
In humans, 5-HT is mostly known for its ability to cause constriction of placental
and umbilical vessels during pregnancy (Melman, 1981). For this reason, many
investigators were interested in the relationship between pregnancy induced hypertension
(PIH) and 5-HT (Gujrati et al., 1996; Schafer et al., 1996; Ren et al., 1997). Ren et al.
(1997) studied the localization and quantification of 5-HT and its receptor (5-HTR) in
placental villi of normal and PIH placentae. Five-HT and 5-HTR immunoreactivity was
positive in syncytiotrophoblasts and capillary endothelium of normal placentae and weak
positive in PIH placentae. The content of 5-HT and 5-HTR was lower in the PIH
placentae than in the normal placentae. Ren et al. (1997) concluded that content of 5HT and 5-HTR in placenta may be related to PIH. Sexton et al. (I 996) localized 5-HT,
histamine and endothelin in subpopulations of endotheli al cells of arteries and veins of
late but not early pregnancy human umbilical vessels. They also exposed the vessels to
different concentrations of 5-HT (10 nM to 30 µM) which caused sustained
concentration-dependent contractions in all vessels from early and late pregnancy.
Sexton et al. ( 1996) concluded that the endothelium may play an autocrine/paracrine role
by synthesizing and releasing reactive substances, such as 5-HT, in late pregnancy to
influence feto-placental blood flow.
To emphasize how varied the actions of 5-HT can be on different species, it has
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been reported (Robson and Sullivan, 1966) that human umbilical vessels in vitro are very
sensitive to 5-HT, however Robson and Sullivan (1963) observed no such action on
mouse vessels in situ. Moreover, in rodents 5-HT is known to cause contraction of the
uterus in vitro, yet Robson and Sullivan ( 1966) observed little increase in uterine tone in
the intact mouse, while oxytocin markedly increased uterine contractions but did not
jeopardize viability of the fetus . However, when Robson and Sullivan (1963) injected 5HT at a dose of 0.5 to 1.5 mg into pregnant mice, the fetuses died within 1 hour, but the
mother suffered no acute toxic effects. The average 5-HT fetal content was 0.117 µgig.

In contrast, when the fetuses were directly injected with I µg to 5 µg of 5-HT, the
fetuses were alive after 1 hour, with no toxic effect, and the average 5-HT fetal content
was 1.098 µgig. They concluded that fetuses died when 5-HT was injected into the
mother, and was probably due to impairment of fetal nutrition, which could have been
caused by hemodynamic changes or reduction of permeability of maternal and fetal
circulation. This conclusion was based on their observation that 5-HT greatly decreased
the passage ofradio-sodium (indicator of placental function) into the placenta.
However, others have reported transplacental transfer of 5-HT from mother to fetus in
the early stages of pregnancy (Yavarone et al. , 1993 ; Prasad et al. , 1996) without
adverse effects to the fetus .
High concentrations of 5-HT in fetal blood compared to maternal or adult blood
were reported by several investigators (Garattini and Valzelli, 1965; De Antoni et al.,
1980; Okatani et al. , 1990; Jeffrey et al. , 1991 ). Using spectrophotometry techniques,
Jeffrey et al. (1991) determined the concentration of 5-HT in fetal bovine serum to be
between 30 µM to 50 µM, whereas the concentration in newborn bovine serum and cow
serum was approximately 1 µM. Their results were consistent with the analyses
conducted by a commercial serum suppli er. Furthermore, tryptophan levels in human
umbilical cord blood collected at birth were high (18 .9 µg/mL), then decreased (10.4
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µg/mL) significantly 24 hours postpartum, and showed a slight but nonsignificant
increase (11.4 µg/mL) 5 days after birth (De Antoni et al., 1980). High tryptophan
levels in fetal blood were confirmed by Okatani et al. (1990) when they reported that 5HT, tryptophan, and 5-IDAA were significantly higher in umbilical cord plasma than in
maternal plasma in humans . In addition to having lower concentrations of 5-HT and
tryptophan, free maternal plasma 5-HT and tryptophan concentrations did not change
during pregnancy. However, free 5-HIAA in plasma increased after 30 weeks of
gestation and reached its peak at 37 weeks. This is an interesting finding because it
suggests one of two possibilities: (1) 5-HT synthesis and degradation are at a steady
state in the mother during this time of gestation, or (2) there is increased degradation of
5-HT in the fetus for preparation of birth. Studies in the rat revealed that in most fetal
tissues, the deaminating activity of MAO reaches it peak within a few days prepartum to
a few weeks after birth (Benedetti et al. , 1992). Lung MAO activity was discovered to
be well developed by 10 days postpartum and reached a maximum by day 40 (Benedetti
et al., 1992), and in rabbits newborn lungs had greater metabolic capacity than both fetal
and adult lungs (Olson et al. , 1983 ). Mantle et al. (1 976) found that fetal rat liver MAO
was similar to adult values from 3 days prepartum, and human placenta MAO activity
increased by 22% at delivery time (Kirkel et al. , 1992). The maturation of the 5-HT
degrading system supports the idea that the fetus is contributing to maternal excretion of
5-HIAA near the end of gestation.
Five-HT was also reported to be involved in postpartum uterine involution.
Collagen content in the pregnant mammalian uterus increases 8- to 10-fold, starting at
the end of the first third of pregnancy and continuing until close to parturition.

Collagenase is required to catal yze the in itial cleavage of collagen that is destined for
removal from the postpartum uterus. In the rat uterus, collagenase is detectable only
during postpartum involution (Jeffrey, 1991). In order for cultured rat and human
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myometrial smooth muscle cells to produce collagenase, they must be stimulated by 5-

HT (Jeffrey et al., 1991) which occurs via the 5-HT2 receptor.
Five-HT was also reported to stimulate cultured bovine luteal cells to produce
progesterone. Battista and Condon ( 1986) treated cultured luteal cells with different
concentrations of 5-HT (1 o·6M to 10-4M) as well as varying concentrations of other
biogenic amines, such as histamine, y-aminobutyric acid, melatonin, and the adrenergic
agent isoproterenol. Individual treatment of the cells with 5-HT and isoproterenol
significantly increased the production of progesterone, whereas the other treatments did
not alter progesterone production. The 5-HT stimulated production of progesterone
was inhibited by the addition of mianserin, a 5-HT antagonist. It was concluded that in
the cow, 5-HT could be involved in the regulation of steroidogenesis by the corpus
luteum.
Other roles for 5-HT have been proposed, such as its involvement in
neuroembryogenesis . Fluorescence histochemical studies demonstrated 5-HT uptake
and synthesis in the notochord, neural tube, and extra-neural regions of the chick embryo
during the first few days of incubation (Lauder et al. , 1981 ), and in the rat 5-HT
depletion can alter the time of genesis of 5-HT target cells. Furthermore, fetal 5-HT
receptors in the forebrain and brainstem were shown to be functional based on their
ability to adapt to changes in the level of 5-HT and therefore capable of playing a role in
neuronal development (Whitaker-Azmitia et al., 1987).
It appears that the involvement of 5-HT in reproduction is not limited to vertebrates
as it has been reported to induce and potentiate parturition in fingernail clams. Fong et
al. (1998) exposed clams to selective serotonin re-uptake inhibitors such as fluoxetine,
fluvoxamine and paroxetine that increase neurotransmission at serotonergic synapses. A
positive parturition response consisted of the release of at least one extra-marsupial larva
from an individual clam. It was discovered that of the selective serotonin re-uptake
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inhibitors used, fluoxetine was the only one that did not induce parturition, however it
did potentiate parturition.
Cellular Proliferation and 5-HT
Five-HT was reported to exert growth stimulatory effects on a number of cell types
(Nemecek et al., 1986; Seuwen and Pouyssegur, 1990; Young et al., 1993). Nemecek et
al. (1986) found that 5-HT at a concentration above 1 µM maximally increased
incorporation of 3H-thymidine into DNA of bovine aortic smooth muscle cells and
stimulated smooth muscle cell mitogenesis to the same extent as human platelet derived
growth factor (PDGF) at 12 ng/mL. Boucek and Alvarez (1969) found that 5-HT at
concentrations of 1o·6 or 10-7 M significantly increased fibroblast cell growth by nearly
100%, however at concentrations of 10·2 and 10·3 M 5-HT was toxic to the cells and
reduced cell numbers by more than 80%. Along with concentration, the time at which 5HT was added to the cells also affected growth . Five-HT given at 0-time increased the
number of cells by 58% within 24 hours. Delaying addition of 5-HT until 1, 2, or 5 days
after the cells had been in culture reduced the stimulatory effect. In order to understand
the mechanism of action of 5-HT on these cells, Boucek and Alvarez (1969) examined
the effect of 5-HT on lag phase of growth. Five-HT increased the number of cells (40%)
attached to the culture flask by 18 hours while in control flasks only 25% of cells had
attached. When growth up to 24 hours was considered , the increase with 5-HT was
greater than 80% while controls were 30% . It was concluded that in the fibroblast cells
5-HT appeared to shorten the lag phase in cell growth. Seuwen and Pouyssegur (1988)
also studied the effect of 5-HT on CHL fibrob last cells. They found that 5-HT
potentiates the mitogenicity of fibroblast growth factor and to a lesser extent epidermal
growth factor and insulin. The mitogenic effect of 5-HT is expressed in the reinitiation
of DNA synthesis and is transmitted by 5-HT rn receptors negatively coupled to adenylate
cyclase. Studies such as this one aid us in understanding regulation of signal
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transduction and the control of cell proliferation. Understanding regulation of cell
proliferation is especially important when faced with abnormal cell growth. Five-HT is
present in hyperplastic human prostate (Abrahamsson et al., 1986). Abdul et al. (1994)
reported the presence of 5-HT binding sites and anti proliferative effects of a 5-HT 1A
antagonist on prostate carcinoma cells. More recently, Abdul et al. (1995) described the
effects of serotonin-uptake inhibitors on different prostate carcinoma cell lines. The
inhibitors used were fluoxetine, zimelidine and 6-nitroquipazine. They found that, in

vitro, the 3 compounds inhibited proliferation of the cell lines studied in a dosedependent manner. They concluded that serotonin-uptake inhibitors could potentially be
used in the treatment of prostate cancer.
Five-HT was also proposed as involved in the growth of embryos. Fluorescence
histochemical studies demonstrated 5-HT uptake and synthesis in the notochord, neural
tube and extra-neural regions of the chick embryo during the first few days of incubation
(Lauder et al. , 1981) and in the rat 5-HT depletion can alter the time of genesis of 5-HT
target cells. Furthermore, fetal 5-HT receptors in the forebrain and brainstem were
shown to be functional based on their ability to adapt to changes in the level of 5-HT and
therefore capable of playing a role in neuronal development (Whitaker-Azmitia et al. ,
1987).
Matrix Metalloproteinases and 5-HT
Matrix metalloproteinases (MMPs) are involved in reproduction in such areas as
placentation (Librach et al. , 1991 ; Polette et al., 1994; Marquoi et al. , 1997), rupture of
membranes (Dieron and Bryant-Greenwood, 1991 ; Bryant-Greenwood, 1998) and
uterine involution (Jeffrey et al. , 1991). Collagenase (MMP-1) was shown to be
produced by myometrial smooth muscle cells in the involuting rat uterus, but not the
pregnant or nonpregnant uterus (Jeffrey, 1991 ). Jeffrey et al. (1991) reported that
cultured rat and human myometri al smooth muscle cells produced collagenase when in
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medium containing fetal bovine serum (FBS) but not in medium containing newborn
bovine serum (NBS) . They isolated the substance in FBS and identified it as 5-HT.
They determined that 5-HT was maximally stimulatory of collagenase production at a
concentration of 5 µM and production of collagenase began after a lag period of 6 hours.
Myometrial smooth muscle cells have an obligatory requirement for 5-HT in order to
produce collagenase whereas other cell types such as fibroblasts can produce collagenase
without stimulation from 5-HT. Five-HT induces collagenase in smooth muscle
myometrial cells by activating the gene for the enzyme (Wilcox et al. , 1994) which is
mediated by the 5-HT2 receptor (Rydelek-Fitzgerald et al. , 1993). Activation of the
collagenase gene was studied further to realize that 5-HT induces interleukin-I mRNAs
and that this production by the myometrial cell is necessary for production of collagenase
(Wilcox et al. , 1994). Recently, it was reported that 5-HT acts as a negative regulator of
alpha2-macroglobulin (an anti-protease) in smooth muscle myometrial cells (Huang and
Jeffrey, 1998) and it has the ability to dow n-regulate type I collagen gene expression
(Passaretti et al. , 1996). Therefore, 5-HT may be a positive or negative regulator of
gene expression.

It is worthy to mention combined injections of 5-HT and ergometrine into pregnant
cows decreased retained placenta' s occurrence from 30% to 10% (Zaiem et al., 1994).
The possibility of 5-HT causing a reduction in the number of retained placentas is of
interest, because it is suspected that the etiology of retained placenta includes lack of
collagenolysis, and it is possible that 5-HT stimulates collagenolysis in the placenta.
Moreover, Maj and Kankofer ( 1997) compared l\tfMP activity in retained and nonretained bovine placenta and found that retained membranes lacked the 64- and 60-kDa
active forms of l\tfMP-2 which may have influenced the hydrolysis of collagen and release
of fetal membranes . In add ition, injections of bacterial collagenase, via umbilical vessels,
into cows with retained placenta has been highl y effective in detaching the placenta
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within 24 hours (Eiler and Hopkins, 1993).
Literature on 5-HT inducing collagenase production in other cell types is limited.
Other than the specific myometrial cell type, 5-HT was reported to stimulate
phospholipase A2 activity, which enhanced collagenase type II activity in chondrocytes
from human osteoarthritic articular cartilage (Richard et al., 1991).
Immunolocalization of 5-HT
Recently, 5-HT and its receptor were localized in human placenta (Ren et al., 1997;
Huang et al., 1998). Huang et al. (1998) used light and electron microscopy techniques
to localize 5-HT in placentae ranging from 6 to 24 weeks of pregnancy. Five-HT and its
receptor were localized in the cytoplasm and on the cell surface of syncytiotrophoblast
microvilli. Nuclei were immunonegative. Cytoplasm of maternal decidual cells showed
strong 5-HT and 5-HT receptor immunoreactivity. Capillary endothelium, white blood
cells in the capillary cavity and stromal cells of placental villi all showed 5-HT receptor
immunoreactivity in the cytoplasm but had negatively stained nuclei. Huang et al. (1998)
also observed 5-HT immunoreactivity in the cytoplasm of trophoblast cells cultured in
serum-free medium, however there were varying degrees of staining intensity among the
cells. Huang et al. (1998) concluded that trophoblast cells produce 5-HT and that 5-HT
may play roles in placental development and pregnancy maintenance by paracrine and
autocrine interactions.
Unlike the conclusion by Huang et al. ( 1998), results of a study by Yavarone et al.

(I 993) led them to conclude that 5-HT present in the mouse placenta is due to uptake
not synthesis. Yavarone et al. (1993) localized 5-HT in the ectoplacental cone and
placenta of the mouse embryo in vivo and in whole embryo cultures. The 5-HT uptake
inhibitor fluoxetine and p-chlorophenylalanine, an inhibitor of 5-HT synthesis were used
to evaluate the ability of the placenta to synthesize and transport 5-HT. Fluoxetine
significantly reduced 5-HT immunoreactivity, however p-chlorophenylalanine had no
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effect on 5-HT immunoreactivity. Furthermore, treatment of embryos with L-tryptophan
did not enhance 5-HT immunoreactivity in the placenta. It is very possible that there are
differences between cells of mouse and human placentae where one has the ability to
synthesize 5-HT and the other does not. It would be beneficial to know if the cells
contain the enzymes required for 5-HT synthesis. If the cells are immunoreactive to 5HT but do not have the enzymes for synthesis, then 5-HT may have been synthesized in
another location and transported to the cells. For the mouse placenta, it was suggested
that the placenta received 5-HT from the maternal circulation. Essman and Cooper
(1978) demonstrated transport of 14 C-5-HT from mother to fetus in the rat.
Furthermore, there is evidence that a 5-HT transporter exists in the brush-border
membrane of the human placenta (Balkovetz et al. , 1989; Ramamoorthy et al., 1995;
Prasad et al. , 1996). The presence of an active mechanism to transfer 5-HT from mother
to fetus suggests that 5-HT may play an important role in regulation of placental function
as well as in the regulation of growth and development of the fetus (Balkovetz et al.,
1989). Transplacental transfer of 5-HT from mother to fetus is effective in early stages
of pregnancy but toward the end of pregnancy maternal 5-HT appears to enter the
placenta but does not reach the fetal circulation (Prasad et al., 1996). It may be that the
fetus is supplying its own 5-HT.
Five-HT appears in endocrine cells of the human intestine as early as 8 weeks of
gestation (Facer et al., 1989) and 12 weeks in the bovine (Totzauer, 1991). Facer et al.
(1989) reported that 5-HT immunoreactive cells increased throughout gestation in the
small intestine but decreased in the large intestine after the second trimester of
pregnancy. Five-HT immunoreactive cells were scattered throughout the villi and crypts
of the intestine. Griffith and Burnstock (1983) also conducted experiments on
localization of 5-HT in the human fetal intestine from 18 .5 to 25 weeks of gestation
using immunofluorescence techniques. Five-HT-like immunoreactivity was found in the
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nerves as well as in the enterochromaffin cells of the intestinal mucosa! villi epithelium of
all studied fetuses . Totzauer (1991), using light microscopy techniques, studied
morphological changes in the bovine fetus duodenal mucosa from 3 months of gestation
until birth. At 3 months, intestinal villi and crypts were formed with enterochromaffin
cells mainly in the crypts. Totzauer (1991) concluded that the advanced state of
development of bovine fetal enteroendocrine cells suggests that they are capable of
producing 5-HT, which corresponds to the time gastrointestinal movements are known
to begin and may be an inducer of muscular motility of the developing intestine.
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PART II
CONCENTRATION PROFILE OF 5-HYDROXYTRYPTAMINE IN
FETAL AND NEONATAL CALF SERUM AND TISSUES
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INTRODUCTION
Five-HT is a well-known neurotransmitter and multi-functional amine with a broad
range of physiological effects including vasoconstriction, bronchoconstriction, platelet
aggregation, intestinal motility, and release of pituitary hormones (Goodman and Gilman,
1975). However, the role of 5-HT in pregnancy, placenta detachment, and delivery is
not well defined. It is know n that 5-HT concentrations in fetal bovine serum (30 µM to
50 µM) are 1. 7 to 50 times greater than 5-HT concentrations in newborn calf serum (1.0
µM to 18 µM) (Jeffrey et al. , 1991 ; Fecteau and Eiler, 1997). In addition to cows, high
5-HT concentrations in fetal blood were also reported for goats and women. For
example, 5-HT, its precursor tryptophan, and its metabolite 5-hydroxyindoleacetic acid
(5-HIAA) were significantl y higher in umbilical cord plasma than in human maternal
plasma (Okatani et al. , 1990). Moreover, De Antoni et al. (1980) demonstrated that
tryptophan levels were very high in human umbilical cord at birth, decreased significantly
24 hours after birth, and showed a slight but not significant increase 5 days after birth.
Also at pregnancy' s end, 5-HT degrading enzymes in fetal liver, fetal lung, and placenta
become active (Benedetti et al. , 1992; Kirkel et al. , 1992), w hich probably contribute to
the low 5-HT concentrations in the neonate. However, the source of high blood 5-HT
concentrations in the fetus is not known . In the mouse, it was found that 5-HT can be
transferred from maternal to fetal circulation in early pregnancy (Yavarone et al. , 1993).
Yet in late pregnancy, 5-HT no longer reached the fetal circulation (Prasad et al. , 1996).
We suspect that the source of fetal blo od 5-HT may be the fetal intestine, since
approximatel y 95% of 5-HT in the body is found in the enterochromaffin cells of the
gastrointestinal tract (Tyce, 1990). Furthermore, it was reported that intestinal resection
caused a significant decrease in blood 5-HT.
The physiological purpose of a high set point for fetal blood 5-HT is puzzling. It is
interesting that when blood concentrations of 5-HT in 200 kg calves were increased by
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IV infusion to roughly fetal concentration, 5-HT became toxic (Aitken and Sanford,
1972; Desmecht et al., 1992). In addition, when Robson and Sullivan (1963) injected 5HT into pregnant mice in the second part of gestation the fetuses died within 1 hour.
However, when the fetuses were directly injected with 5-HT all fetuses were alive and
without any toxic effects after 1 hour. The reason for high 5-HT tolerance by the fetus is
not known. It is suspected that high concentrations of 5-HT in fetal blood may favor
pregnancy. It is speculated that 5-HT may act as a "proliferation factor" to sustain both
placental growth and placental cell turnover during pregnancy. Supporting this view is
the fact that growth stimulatory effects of 5-HT were described on a variety of cell types
(Nemecek et al., 1986; Takuwa et al. , 1989; Seuwen and Pouyssegur, 1990; Ishizuka et
al. , 1992). It was also proposed that 5-HT may have a role in fetal growth processes
(Garattini and Valzelli, 1965 ; Lauder et al. , 1981 ; Whitaker-Azmitia et al., 1987),
however, information on 5-HT and placental growth is scarce. It is known that the
human placenta possesses 5-HT receptors and 5-HT has been localized in cells of the
placenta (Huang et al., 1998). Therefore, based on its proliferative effects on various
cell types, its presence in the placenta, and high fetal blood concentrations we
hypothesize that 5-HT from bovine fetal intestine acts as a " proliferation factor" to
support placental cell growth during pregnancy. In our hypothesis, partial withdrawal
(by decreased secretion and/or increased inactivation) of fetal blood 5-HT is a cause for
both (1) arrest of placental cell proliferation and (2) activation of matrix
metalloproteinases (MMPs). Activation of MMPs contributes to placenta detachment at
parturition. A systematic study including the determination of 5-HT in fetal blood and
fetal tissues at different stages of pregnancy is lacking. It was our objective to determine
the concentration profile of 5-HT in fetal tissues and blood of bovine fetuses at different
times during gestation and delivery, in calves up to 3 days postpartum and in adult cows.
This information is needed in order to assist in the identification of a potential role of 524

HT in pregnancy and parturition. If there is a pattern of concentration change in fetal
blood 5-HT, physiological correlates can be unfolded.

MATERIALS AND METHODS
Blood and Tissue Collection
Intestine (middle jejunum, approximately 1 meter from large intestine), skeletal
muscle (semitendinosus), placenta (cotyledon and caruncle), and blood (obtained by
heart puncture) were collected from mid and full gestation fetuses at an abattoir within
20 minutes of slaughter. Fetal age was approximated using a fetal development chart
(Roberts, 1971). Mid-term pregnancy was considered between 180 days and 240 days
and full-term pregnancy was considered

270 days . Blood and intestine were collected

from cows at an abattoir. Intestine and muscle samples and blood were collected from
24 hour old and 48-72 hour old male calves obtained from The University of Tennessee
Dairy Farm. Calves were euthanized immediately after blood collection and prior to
muscle and intestine collection with a cardiac injection of Beuthanasia-D Special (20 mL)
(Schering Plough Animal Health Corporation). Postpartum cotyledons (fetal membranes
of placenta) were obtained from cows with hangi ng membranes after natural delivery at
The University of Tennessee Dairy Farm. Blood was collected from the umbilical cord
veins of fetuses during delivery by cesarean section and from the jugular vein of cows
prior to cesarean section. Blood was collected into vacutainer tubes without
anticoagulant. AJI tissue samples were put into plastic bags and placed on ice for
transport to the laboratory.

In the laboratory, blood was centrifuged at I ,700 g for 30 minutes, then serum was
removed and placed in a labeled tube and frozen at -20°C until analyzed . Tissues (1 g)
were homogenized (Virtis homogenizer) in 0.2 N HC1O 4 (10 µL/ mg tissue) for 5
minutes, sonicated for 15 minutes, then centrifuged for 5 minutes at 10,000 g . The
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homogenates were filtered through a 0.22 µm filter, then the supernatant was neutralized
by addition of an equal volume of borate buffer (pH 9 .25). The samples were then
centrifuged for 1 minute at 10,000 g and placed in labeled tubes and stored at -20°C until
analyzed. Samples were analyzed using an enzyme immunoassay kit (Immunotech,
Marseille, France).

Enzyme Immunoassay Performance
Serum and cotyledon samples were used to determine performance characteristics of
the 5-HT immunoassay for bovine samples. The parameters used were intra-assay and
inter-assay variation, parallelism, recovery and specificity. In order to determine
variation within the assay, each sample was processed in duplicate and the coefficient of
variation was calculated by dividing the standard deviation by the mean and multiplying
by 100. Parallelism was determined by assaying undiluted and diluted samples. The
samples were diluted in the following ratios : 1:2, 1 :4, and 1 :8. To determine recovery,
samples were spiked in a 1: 1 ratio with high (200 nM), medium (60 nM) and low (1 .6

nM) 5-HT concentration solutions. Percent recovery was calculated by dividing the
observed value by the expected value. Specificity (cross-reactivity) was tested by adding
norepinephrine (expected released in large quantities during slaughter) to wells at an
equimolar concentration to 5-HT when at 50% maximal absorbance .

Enzyme Immunoassay Procedure
Serum samples were diluted 1:200 with 1 M borate buffer. Tissue samples were left
undiluted or diluted 1:5 with a l : 1 solution of 1 M borate buffer/0.2 M HC1O 4 . For
serum samples, the standard curve was prepared using standard supplied with the kit and
lM borate buffer for dilutions . The standard curve for tissues was prepared using
standard supplied with the kit and borate buffer / HC1O4 as diluent.
Standards (200 nM, 60 nM, I 8 nM, 5.4 nM, 1. 6 nM, and 0 nM) were prepared, and
assay was performed according w ith manufacturer' s instructions (Appendix) .
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Statistical Analysis
Statistical analysis was performed using the General Linear Models procedure in

SAS . Probability of significance was reported at P

0.05 . Least Square Means were

computed and compared using least significant difference techniques.

RESULTS
Assay Performance
Results of intra-assay and inter-assay variation for serum samples are shown in
Tables 2.1 and 2.2, respectively. Results of parallelism and recovery for serum samples
are shown in Tables 2.3 and 2.4, respectively. Results of intra-assay and inter-assay
variation for tissue samples are shown in Tables 2.5 and 2.6, respectively, and results of
parallelism for tissue are shown in Table 2.7.
Specificity ( cross-reactivity) of the assay was tested using norepinephrine at
equimolar concentration to 5-HT investigated at 50 % maximal absorbance. Crossreactivity was undetectable. Manufacturer specification reported different degrees of
cross-reactivity with analogs. Cross-reactivity was expressed as the ratio of analog
concentration/acylated 5-HT concentration at 50% maximal absorbance. Crossreactivity of analogs, such as N-succinyl 5-HT, acylated tryptamine, acylated 5hydroxytryptophan and acylated tryptophan varied between 2.8 for N-succinyl 5-HT to
1,000,000 for acylated tryptophan . Sensitivity of the assay is approximately 0.5 nM as
determined by the manufacturer.
Assay performance was considered satisfactory. However, variability in tissue
samples was larger than for serum samples; that was expected since in tissues there are
more interfering substances. Dilution affected tissue samples markedly. Dilution of
tissue samples (but not serum dilution) resulted in increased concentrations. Dual
homogenization and ultrasound did not decrease variability in tissues compared to
homogenization only. In this assay, there was no extraction step, which tends to retain
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Table 2.1. Intra-assay variation for calf serum assay
Coefficient of
Variation (%)

Sample

5-HT (nM)

Pool I
Pool 2
Pool 3

22,000 ± 3,960
17,400 ± 1,260
9,400 ± 820

18.0
7.2
8.7

Abbrev1at1on: 5-HT, 5 hydroxytryptamme
Mean+ SD, n=6

Table 2.2. Inter-assay variation for calf serum assay
Coefficient of
Variation (%)

Sample

5-HT(nM)

Pool 1
Pool2

27,600 ± 3,060
13,000 ± 980

11.0
7.5

Abbreviation: 5 Hydroxytryptamme
Mean + SD, n = 6

Table 2.3. Serial dilution of calf serum for evaluation of parallelism
Serum
Dilution
Undiluted
1:2
1:4
1:8

5-HT Observed (0)
(nM)

0/E X 100
(%)

5-HT Expected (E)
(nM)

32,000 ± 848
11,800 ± 1,4 14
7,600 ± 580
3,600 ± 320

16,000
8,000
4,000

74
95
89

Abbreviation : 5-HT, 5-hydroxytryptamine
Mean + SD, n = 6

Table 2.4. Spiking recovery from calf serum
Spiking
Solution (nM)
Sample
High
Medium
Low

5-HT Observed (0)
(nM)

5-HT Expected (E)
(nM)

10,000 ± 1,2 70
24,000 ± 800
9,600 ± 580
5,660 ± 130

25,000
10,000
7,800

0/E X 100
(% Recovery)
96
96
72

Mean + SD, n = 6
High= 200 nM; Medium= 60 nM; Low = 1.6 nM
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Table 2.5. Intra-assay variation for cotyledon tissue assay
Sample
Postpartum cotyledon

5-HT (ng/g)

Coefficient of
Variation (%)

1,250 ± 1,405

32

Abbreviation: 5-HT, 5 hydroxytryptamine
Mean +SD, n = 8

Table 2.6. Inter-assay variation for cotyledon tissue assay
Coefficient of
Variation(%)

Sample

5-HT (ng/g)

Cow 1

845 ± 298

35

Cow 2

1720 ± 553

32

Abbreviation: 5-HT, 5 hydroxytryptamine
Mean +SD, n = 6

Table 2. 7. Serial dilution of cotyledon samples for evaluation of parallelism
Sample
Dilution

5-HT Observed (0)
(ng/g)

5-HT Expected (E)
(ng/g)

0/E X 100
(%)

Undiluted

1480 + 303

1:2

1005 + 285

740

136

1:4

840 + 398

370

228

1:8

530 + 208

185

286

Abbreviation : 5-HT, 5-hydroxytryptamine
Mean+ SD, n= 6
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interfering substances. In order to minimize artifacts, samples for a given experiment
were analyzed in a single assay. For large numbers of samples, assay kits from the same
lot were used . When possible, sample dilution for tissues was avoided. When values
were off-scale, samples were diluted and reanalyzed . Concentrations of serum 5-HT in
our study were consistent with those reported by Jeffrey et al. (1991) for FBS, however
our 5-HT concentrations in NBS were slightly higher.
Enzyme Immunoassay for 5-HT

Sentm5-HT
Analysis of serum revealed significant (P :S 0.0001) differences in 5-HT
concentration at different stages of gestation and postpartum. The mean ± SEM
concentration of 5-HT in blood of mid-term gestation fetuses (54,111 nM ± 6,574 nM)
and full-term gestation fetuses (51,640 ± 4,880 nM) was significantly higher than fetuses
during delivery by cesarean section (13 ,625 nM ± 5,576 nM), 24 hour old calves (24,460
nM ± 2,947 nM), 48-72 hour old calves (18 ,400 ± 2,519 nM) and cows (8,004 nM ±
1,203 nM). Interestingly, blood obtained from fetuses during cesarean section was not
significantly different (P

0.0001) in 5-HT concentration from blood obtained from

newborn calves and adult cow. However, newborn calf blood contained significantly (P
:S 0.0001) higher concentrations of 5-HT compared to adult cow (Figure 2.1).

Tissue 5-HT
The mean± SEM concentrations of intestinal 5-HT in mid-term (5,321 ng/g ± 943
ng/g) and full-term (7,059 ng/g ± 1,636 ng/g) gestation fetuses and 48-72 hour old
calves (6,618 ng/g ± 430 ng/g) were significantly (P :S 0.0001) higher than
concentrations from 24-hour old calves (1,410 ng/g ± 248 ng/g) and adult cow (3,049
ng/g ± 851 ng/g) intestines. There was no significant difference (P

0.0001) in 5-HT

concentration between 24-hour old calf intestines and adult cow intestines (Figure 2.2).
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Figure 2.1. Concentration of 5-HT in serum of fetuses at mid-term and full-term pregnancy,
fetuses during cesarean section, newborn calves at 24 and 72 hours old, and adult cows.
Columns are mean± SE for a minimum of 5 animals per group. Different letters (a,b,c)
represent significant difference (P 0.05) among groups. Letters MT, FT, and CS indicate
stage of fetus as mid-term, full-term, and cesarean section, respectively.
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Figure 2.2. Concentration of 5-HT in intestinal wall of fetuses at mid-term and full-term
pregnancy, newborn calves at 24 and 72 hours old, and adult cows . Columns are mean ± SE for
a minimum of 5 animals per group. Different letters (a,b,c) represent significant difference (P
0.05) among groups. Letters MT and FT indicate stage of fetus as mid-term and full-term ,
respectively.
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The mean± SEM concentration of placental 5-HT in mid-term (4,570 ng/g ± 1,710
ng/g) and full-term (5,788 ng/g ± 956) gestational fetuses was significantly higher (P
0.0001) than postpartum cotyledon (1 , 176 ng/g ± 199 ng/g) (Figure 2.3).
The mean± SEM concentration of muscle 5-HT was high (P

0.0001) in full-term

gestation fetuses (4,941 ng/g ± 714 ng/g) and low in mid-term gestation fetuses (1,412
ng/g ± 270 ng/g) and 24 hour old calves (1,759 ng/g ± 192 ng/g) . There was no
difference in 5-HT concentration between muscle from mid-term gestation fetuses and
muscle from 24-hour old calves (Figure 2.4).
Comparing changes in 5-HT concentration among tissues at common stages of
gestation or postpartum revealed that there were significant (P

0.0001) differences

between intestine and placenta from mid gestation fetuses, intestine and muscle from full
gestation fetuses, muscle and placenta from full gestation fetuses, and intestine, muscle
and placenta from 24 hour old calves. An overall view of the relative concentration
changes in 5-HT is depicted in Figure 2.5.

DISCUSSION
The main finding of this work was that concentrations of 5-HT in fetal blood were
extremely high in both mid and full gestation fetuses, and was then dramatically
decreased to approximately one-fourth of fet al concentration (from 53 µM to 14 µM)
during cesarean section deli very. In our experiment, it was not possible to establish the

exact time at which 5-HT concentration dropped in fetal blood in relation to delivery
time. However, concentrations of blood 5-HT in fetuses delivered by cesarean section
were already low. The use of a chronic fetal catheter (Ford, 1995) may aid in
determining when 5-HT concentration decreases in the fetus .
Our results using serum samples collected from individual fetuses are in close
agreement with dat a obtained from pool ed samples (3 0 µM-50 µM) obtained from a
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Figure 2.5. Synopsis of relative concentration changes of 5-HT in intestine, blood,
placentome, and skeletal muscle of fetuses at mid- and full-term pregnancy, neonatal
calves at 24 and 72 hours postpartum, and adult cows. Level of open circles within a
line indicates no change (same), decrease (down), or increase (up) of 5-HT
concentrations (P :S 0.05). Figure illustrates the hypothesis that 5-HT is secreted by the
fetal intestine into fetal blood circulation, bathing placentomes, and fetal muscles. High
levels of fetal blood 5-HT stimulate cell proliferation and inhibit :M1v1P activity in the
placentome. Decrease in fetal blood 5-HT at partum acts as a withdrawal signal to the
placentome causing arrest of cell proliferation and inducing :M1v1P activity, leading to
placenta detachment.
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commercial source (Jeffrey et al. , 1991 ). However, in our experiment 5-HT
concentration in neonatal calves (18 µM) was moderately higher than the concentration
for commercially obtained pooled-newborn bovine serum (1.0 µM) as reported by
Jeffrey et al. (1991). The discrepancy in reported concentrations of newborn bovine
serum may be explained , in part, by techniques used for analysis of 5-HT and the source
of samples.
When concentrations of 5-HT in blood were elevated tissue concentrations were
also elevated. High blood and tissue concentrations of 5-HT may have resulted from
increased secretion from the intestine and/or low 5-HT metabolism by degradative
enzymes. The drop in 5-HT concentrations in the intestinal wall and blood of 24 hour
old neonatal calves to one-fourth that of pregnancy concentrations, suggested to us that
there may be a decrease in 5-HT secretion from the intestine and perhaps an increase in
5-HT degradation. However, 5-HT concentration in the skeletal muscle in mid
pregnancy was low when blood concentration was high . It may be that skeletal muscle is
not a primary target tissue of 5-HT in mid pregnancy. Also, 5-HT concentration
increased in the intestinal wall at 72 hours postpartum when concentration in blood was
low. This transient increase of 5-HT concentration in the intestinal wall at 72 hours
postpartum suggested that 5-HT could regulate intestinal motility. The stimulatory
effect of 5-HT on intestinal motility is well known (Goodman and Gilman, 1975) and
calves that are 72 hours old are capable of nursing regularly, thereby causing stimulation
of their gastrointestinal system. During embryonic development, 5-HT is strictly related
to the development of the enterochromaffin system (Garattini and Valzelli , 1965). It has
been demonstrated through immunohistochemical techniques that enterochromaffin cells
appear in the intestine as early as 3 months of gestation in the bovine fetus (Totzauer,
1991) and 2 months in the human fetus (Facer et al. , 1989). In experimental animals and
humans (Goodman and Gilman, 1975), removal of segments of the small intestine lowers
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the level of 5-HT in serum, yet, blood levels are not drastically affected when the large
intestine is removed (Garattini and Valzelli, 1965). These facts suggest that blood levels
of 5-HT can be adjusted by decreasing or increasing intestinal secretion of 5-HT in the
fetus. It should not be ignored, however, that maternal blood is also a potential source
for fetal 5-HT. It was reported by Yavarone et al. (I 993) that the placenta is capable of
transferring 5-HT from the mother to the fetus in early stages of pregnancy. However,
near the end of pregnancy maternal 5-HT appears to enter the placenta but does not
reach the fetal circulation (Prasad et al., 1996). It has been reported that monoamine
oxidase (MAO) activity in human placenta increased by 22% at time of delivery (Kirkel
et al., 1992) which may explain, in part, why maternal 5-HT does not reach fetal
circulation.
It is interesting that MAO activity in many body tissues, such as lung, brain and
kidney, is not well developed until approximately 1 to 2 weeks postpartum, unlike the
binary system (MAO-A, MAO-B) in rat liver which is fully developed at least 3 days
prepartum (Benedetti et al. , 1992). Uptake and degradation by the lung are important in
the metabolism of 5-HT. Depending on the rate of infusion 30% to 90% of 5-HT is
taken up by pulmonary endothelial cells and metabolized primarily by MAO (Vane,
1969). In sheep, the uptake of 5-HT by the fetal lung is greater than in postnatal stage
(Balaguer et al. , 1992). It may be that the development of MAO deaminating activity is,
in part, responsible for the drop in fetal serum 5-HT concentrations during delivery. At
birth human concentrations of 5-HT and its metabolite, 5-HIAA, were significantly
higher in umbilical cord plasma than in maternal plasma, which indicates a more rapid
metabolism of 5-HT in the fetus than in the mother (Okatani et al. , 1990). It is likely
that a combination of increased metabolization of 5-HT by fetal tissues and a decreased
secretion of 5-HT by the intestine may regulate relative concentrations of 5-HT in fetal
blood.
37

In conclusion, our results of 5-HT concentration change in fetal blood and tissues
during gestation and delivery, along with supporting literature, suggest that 5-HT is
involved in normal pregnancy and delivery. The role that 5-HT plays in normal
pregnancy is not fully elucidated, however we suspect it may be involved in processes
that control growth of the placenta and fetus. The unanswered question of the function
of 5-HT in pregnancy creates a novel path for future research.
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APPENDIX
Enzyme Immunoassay Procedure
40 µL of reconstituted standard plus 1960 µL dilution buffer
300 µL of200 nM standard plus 700 µL dilution buffer
300 µL of 60 nM standard plus 700 µL dilution buffer
300 µL of 18 nM standard plus 700 µL dilution buffer
300 µL of 5.4 nM standard plus 700 µL dilution buffer
1000 µL dilution buffer
1)

Add 100 µL sample or standard to acylation tube (for serum samples also add
50 µL of acylation buffer), vortex to dissolve reagent.

2)

Incubate in dark at room temperature for 30 minutes.

3)

Add 20 µL of sample or standard, in duplicate, to microtiter wells (leave one
well empty for substrate blank) .

4)

Add 200 µL of enzyme conjugate to each well except substrate blank.

5)

Incubate plate in the dark at room temperature with shaking at 3 50 rpm for 3
hours.

6)

Add 200 µL of substrate to all wells and incubate plate as above for 15
minutes.

8)

Add 50 µL of stop solution to wells.

9)

Read plate at 40 5-414 nM.

10) Plot absorbance of standards versus concentration of stand ards to determine
concentration of samples.
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PART III
EFFECT OF 5-HYDROXYTRYPTAMINE ON BOVINE
PLACENTAL CELLS:
GROWTH STIMULATORY OR INHIBITORY?
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INTRODUCTION
Growth stimulatory effects of 5-HT on a variety of cell types have been described.
Five-HT sensitive cells include bovine aortic smooth muscle cells (Nemecek et al., 1986),
hamster lung fibroblasts (Seuwen and Pouyssegur, 1990), renal mesangial cells (Takuwa
et al., 1989), rat intestinal epithelial cells (Tutton et al., 1987) as well several types of
carcinomas (Ishizuka et al., 1992; Cattaneo et al. , 1993). Furthermore, it has been
proposed that 5-HT may have a role in fetal growth processes (Garattini and Valzelli,
1965), such as in neuronal development in the chick and rat (Lauder et al. , 1981 ;
Whitaker-Azmitia et al., 1987). Therefore, 5-HT has been widely documented to be a
mitogen in many tissues. However, information on proliferative effects of 5-HT on
placental tissues is scarce. Recently, Huang et al. (1998) localized 5-HT and its receptor
in human placenta and several researchers have reported the existence of a 5-HT
transporter in the maternal-facing brush border membrane of the human and mouse
placenta (Balkovetz et al. , 1989; Ramamoorthy et al. , 1995 ; Prasad et al., 1996). The
purpose of the transporter is not known but may serve to regulate placental function,
and/or act in growth and development of the fetus (Balkovetz et al. , 1989). Moreover,
5-HT concentrations in fetal bovine serum have been reported to be 30 to 50 times
higher than neonatal and cow serum (Jeffrey et al. , 199 1; Fecteau and Eiler, 1997). The
source of this high fetal 5-HT is not know n, however it is suspected that the intestine
may be the source since approximately 95% of body 5-HT is located in the
enterochromaffin cells of the gastrointestinal system (Tyce, 1990). It is our hypothesis
that 5-HT from bovine fetal intestine acts as a " proliferation factor" to support placental
cell growth during pregnancy. In our hypothesis, partial withdrawal (by decreased
secretion and/or increased inactivation) of fetal blood 5-HT is a cause for both (1) arrest
of placental cell proliferation and (2) acti vation of matrix metalloproteinases (M:MPs).
Activation of l\1MPs contributes to placenta detachment at parturition. This hypothesis
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is appealing because it links unexplainably high concentrations of 5-HT in fetal blood
with well-accepted mitogenic effects of 5-HT. Therefore, to determine if our hypothesis
was valid in our suggestion that 5-HT was a proliferation factor for placenta, we
assessed the growth stimulatory effect of 5-HT on bovine placental cells by direct cell
count and two proliferation assays: (1) incorporation of 3H-thymidine into DNA, and (2)
a tetrazolium based colorimetric assay.

MATERIALS AND METHODS

Cell Culture Reagents and Materials
Dulbecco's Modified Eagle Media (D:MEM)/F-12 (50/50) Nutrient Mixture and
trypsin-EDT A (1 X) solution were obtained from Fisher Scientific (Pittsburgh, PA); fetal
bovine serum (FBS), antibiotic-antimycotic (ABAM, l0OX) solution, prepared with
10,000 units/mL penicillin G sodium, 10,000 µg/mL streptomycin, and 25 µg/mL
amphotericin B, and insulin-transferrin-selenium-X (100 X, ITS) were obtained from
Life Technologies/Gibco BRL (Grand Island, NY) ; epidermal growth factor (100
µg/vial, EGF) was obtained from Becton Dickinson (Bedford, MA); Hank's Buffered
Salt Solution (HBSS, 10 X) and 5-hydroxytryptamine hydrochloride were obtained from
Sigma Chemical Company (St. Louis, MO); [methyl- 3H) Thymidine, specific activity 25
Ci/mmol, was obtained from Amersham Life Science (Arlington Heights, IL); selfaligning glass fiber filters were purchased from Packard (Meriden, CT), and CellTiter 96

AQucous One Solution Cell Proliferation Assay was obtained from Promega Corporation
(Madison, WI).
Tissue Collection and Cell Culture Preparation
Primary exp Iants of bovine placenta were prepared in our laboratory and Dr. Linda
Munson (Davis, CA) donated characterized trophoblast cells (Munson et al. , 1988) for
use.
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Placentomes were obtained from mid-term (180 days to 240 days) gestation fetuses
and full-term (~ 270 days) gestation fetuses at Brown Packing Company, Gaffney, SC.
Fetal age was approximated using a growth development chart (Roberts, 1971). Fetuses
were considered full-term gestation if hair coat was complete and incisor teeth were
erupted and sharp . Fetal (cotyledon) and maternal (caruncle) tissues of individual
placentomes were separated manually. Pieces of cotyledonary villi as well as caruncular
tissues were cut with a sterile scalpel and placed in 50 mL sterile centrifuge tubes
containing DMEM /Fl2 cell culture medium, 10% FBS, ABAM, EGF and ITS, and
were placed on ice for return to the laboratory. Once in the laboratory, tissues were
processed based on a method by Freshney (1994), however slightly modified . Tissue
pieces were placed in sterile disposable Petri dishes and minced into small pieces.
Minced tissues were placed in 15 mL sterile centrifuge tubes containing HBSS and
washed allowing the tissues to settle to the bottom of the tube. Tissue pieces were
removed from the tube using a 1 mL pipette and placed in a 25 cm 2 Primaria tissue
culture flask . Excess fluid was removed and 1 mL of fresh medium was placed in the
flask. Flasks were placed in a humidified incubator supplied with 5% CO 2 and 95 % air.
Tissues were allowed to adhere to the flask for 24-48 hours then 1 mL of media was
added to the flask each day until fluid volume equaled 5 mL. The medium in flasks was
changed as needed and when the outgrowth of cells reached 50 % confluence or greater,
the cells were harvested by trypsinization and passed into 75 cm2 flasks . When cells
reached at least 80% confluence, they were used in proliferation experiments.
3

H-thymidine Assay
Cells were harvested from flasks by trypsinization, then centrifuged for 10 minutes

at 1000 g. Cells were then tested for viability by adding 100 µL of cell suspension to
100 µL trypan blue and counting live cells (dead cells turn blue) on a hemacytometer.
Once the number of live cell s was determined, different cell densities (500, 1,000, 5,000,
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and 10,000) were suspended in 200 µL DMEM/Fl2 supplemented with 10% FBS, EGF,
ITS, and ABAM, then cells were plated in a 96-well tissue culture plate. No cells were
plated in 8 of the wells so as to serve as blanks. The plate was then placed in the
incubator. Cells were allowed 24 hours to adhere, then were washed with DMEM/Fl2
and 200 µL DMEM/Fl2 was added to each well. The plate was placed in the incubator
for another 24 hours. After 24 hours, cells were washed with DMEM/Fl2, and 5-HT at
a concentration of 5 µM was added to the wells. Control wells contained cells but no 5HT. Eight hours after addition of 5-HT, 3H-thymidine at a concentration of 1 µCi/20 µL
was added to all wells except blanks. The plate was left to incubate for a total of 24
hours. The next day, the plate was either placed in a -20°C freezer for 2 days or fluid
was aspirated, washed, then 5% trichloroacetic acid was added, aspirated, then 0.2 N
NaOH was added to obtain acid-insoluble fraction . After either procedure, the plate was
harvested onto a glass fiber filter and disintegrations per minute (dpm) were determined
on a beta counter. The same procedure was conducted with 10,000 cells and different
concentrations of 5-HT (2.5, 5, and 10 µM) to establish a dose response.
Colorimetric Proliferation Assay
Different cell densities (500, 1000, 5000 and 10,000) suspended in 100 µL
DMEMIF12 supplemented with 10% FBS, EGF, ITS , and ABAM were plated in a 96well tissue culture plate. After 48 to 72 hours in an incubator, 20 µL of CellTiter 96

AQueous One Solution Reagent were added to all wells. The plate was incubated for 4
hours, then analyzed at a wavelength of 490 nm on a microplate reader (Cambridge
Technology, Inc.). A similar procedure was performed with different concentrations of
5-HT. Briefly, 10,000 cells suspended in 100 µL DMEM/Fl2 supplemented with 10%
FBS, EGF, ITS , and ABAM were plated in a 96-well tissue culture plate. No cells were
plated in 8 of the wells so as to serve as blanks. The plate was then placed in the
incubator. Five-HT, at concentrations of2 .5, 5. 0, and 10.0 µM, was either added to
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cells when plated or 24 to 48 hours later. Cells were incubated for a total of 4 days. On
the 4 th day, 20 µl of CeIITiter 96 AQueous One Solution Reagent were added to all wells.
The plate was incubated for 4 hours, then analyzed at a wavelength of 490 nm on a
microplate reader.
Hemacytometer and Coulter Counter Cell Count
Cells from primary explants were plated at a density of 20,000 placental cells/75 cm2
flask. Experimental groups consisted ofDMEM/Fl2 plus 5 µM 5-HT, DMEM/Fl2
supplemented with 10% FBS plus 5 µM 5-HT, and DMEM/Fl2 supplemented with 10%
charcoal-stripped FBS plus 5 µM 5-HT. Control flasks contained no 5-HT. Cells were
counted at 24, 48, and 72 hours. To obtain a cell count, cells were harvested from the
flasks by trypsinization and centrifuged at I 000 g for 10 minutes. For hemacytometer
counts, cells were resuspended in 10 mL of media of which 100 µL was mixed with 100
µL oftrypan blue and placed on a hemacytometer. Number of cells/mL was determined
using the following formula : average obtained from counting 8 grids x 2 x 10 x 1000.
For Coulter counter counts, 250 µL of cell suspension were placed in a beaker with 50
mL oflsoton solution. The machine counted the cells in 2.0 mL increments for an
average of 5 counts/beaker. Number of cells/mL was determined using the following
formula : (l/Vc)(1Ns)(V1) , where Ve represented monometer or increment volume, Vs
represented sample volume, and V1 represented Isoton and sample volume. Size of cells
was also analyzed on the Coulter counter.
Statistical Analysis
Statistical analysis was performed using the General Linear Models procedure in
SAS . Probability of significance was reported at P

0.05 . Least Square Means were

computed and compared using least significant difference techniques. In order to
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stabilize the variance, the natural log of concentration means and cell number means
from the 3H-thymidine experiments was used.

RESULTS
Incorporation of 3H-thymidine into DNA
As cell number increased so did incorporation of 3H-thymidine (r = 0.94). There
were significant (P :5: 0.0001) differences among all cell numbers except 5,000 and
10,000 (Figure 3.1). When various concentrations of 5-HT were used to treat a uniform
number of cells, incorporation of 3H-thymidine increased with increasing concentration
of 5-HT. All treated groups were significantly different (P :5: 0.0001) from control,
however 5 µMand 10 µM were not significantly (P

0.0001) different from each other

but were significantly (P :s; 0.0001) different from 2.5 µM 5-HT (Figure 3.2).
Colorimetric Proliferation Assay
When no 5-HT was added to cells absorbance increased significantly (P :5: 0.0001)
with increasing cell number (Figure 3 .3) indicating that there were more viable cells in a
well plated with 10,000 cells versus a well with 500 cells. When different concentrations
of 5-HT were added to a uniform number of cells there was decreased absorbance (less
colored product formed) suggesting decreased viability of cells. Control cells produced
significantly (P :5: 0.0001) more colored formazan product than 5-HT treated cells, and
10 µM 5-HT were significantly (P :5: 0.0001) more inhibitory than 2.5 µMand 5 µM
(Figure 3 .4).
Cell Count and Cell Size
There were no significant differences (P

0.60) observed in cell number between

cells treated with 5 µM 5-HT and cells used as control. Using a hemacytometer, the
mean cell count when 5-HT was added was 68,599 cells/mL and 61,989 cells/mL for
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control cells. Mean cell numbers obtained from use of the Coulter counter were 49,989
cells/mL for 5-HT treated groups and 56,599 cells/mL for control groups. Along with
cell number, mean cell size did not differ significantly (P

0.46) between 5-HT groups

(25 .6 µm) and control groups (25.3 µm).

DISCUSSION
The objective of this research was to determine whether or not 5-HT acts as a
"proliferation factor" for bovine placental tissues . The results of these experiments
indicated that treatment of bovine placenta cells with 5-HT increased incorporation of
3

H-thymidine into DNA of cells (increased mitogenic activity) . However, 5-HT reduced

color change in a colorimetric proliferation assay ( decreased viability/proliferation), and
had no visible effect on cell count and cell size. The dissociation in results between
incorporation of 3H-thymidine and the tetrazolium-based colorimetric proliferation assay
was unexpected, since it has been reported that there is less than 5 % difference between
the two assays (Piva et al. , 1996). The reason for the inconsistency between the results
of the two assays is not known .
One should keep in mind that the basis of the two assays is intrinsically different as
one assay is based on synthesis of DNA, and the other is based on metabolism of
tetrazolium to a colored formazan product. It is generally accepted that cells that
incorporate 3H-thymidine into their DNA will proceed to mitosis. In order to

incorporate thymidine into DNA the thymidine must be taken up by the cells and
phosphorylated stepwise. The thymidylate kinases which act in the phosphorylation of
thymidine are absent from non-growing cells and vary dramatically throughout the cell
cycle. Thus, phosphorylation may be a rate-limiting process except in S- and G2-phases
of the cell cycle (Adams, 1990).

In the tetrazolium-based assay, the tetrazolium compound is bioreduced by cells into
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a colored formazan product that is soluble in tissue culture medium. The conversion of
tetrazolium to formazan is thought to be accomplished by NADPH or NADH produced
by dehydrogenase enzymes in metabolically active cells (Promega Technical Bulletin,
1996). Metabolically active cells are assumed capable of proliferation. It is of interest
though, that not all cell lines are equal in their reduction capabilities to form the colored
product. This concern prompted researchers using drug-screening protocols to examine
parameters affecting formazan production (Vistica et al., 1991). It was found that
culture age and concentration of D-glucose in culture medium affected formazan
production. Cell lines that extensively metabolized D-glucose exhibited the greatest
decrease in formazan production. These findings indicated that the kinetics of formazan
production and degree of saturation vary in a cell line-specific manner (Vistica et al.,
1991). Our placental cell cultures were used at early passages but glucose metabolizing
capability of these cells that were treated with 5-HT was not known . We conducted a
pilot experiment (unpublished and not reported in this manuscript) in which oxygen
uptake and radioactive carbon dioxide, that were formed from uniformly-labeled
radioactive D-glucose (New England Nuclear, Boston, MA), were measured in cultured
placental cells with and without 5-HT. The medium used for treated and untreated cells
contained stable glucose and insulin. Results of preliminary data from our laboratory
indicated that 5-HT increased decarboxylation of radioactive D-glucose by cultured
bovine placental cells. If this is true, then it may be that increasing concentrations of 5HT caused the cells to metabolize more gluco se hence decreasing formazan production
by 5-HT treated cells in a dose-related manner. It may be that 5-HT re-directed
NADPH, NADH or enzymes that were needed to bioreduce tetrazolium into a different
biosynthetic pathway, resulting in decreased color production. Therefore, based on the
inherent differences in the two proliferation assays the results should not be considered
contradictory.
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Since 5-HT had positive effects on placental cell incorporation of 3H-thymidine, it is
puzzling that cell number and size did not increase when cells were treated with 5-HT. It
is possible that, in vitro, 5-HT inhibited metabolic reactions that were needed to
complete proliferation in the placental cell, yet was capable of activating DNA synthesis.
Also, it may be that 5-HT requires additional growth factors, as is the case with vascular
smooth muscle cells (Nemecek et al., 1986), in order to stimulate cell growth. Further,
our primary cultures were a heterogeneous population of placental cells. Since we were
interested in placental growth, we thought the logical starting point for cell growth
studies would be a mixture of cells representative of the placenta. Perhaps a small
population of cells in this mixture was actually affected by 5-HT, and that effect was too
small to detect when counting cells or determining cell size. The obvious next step
would be to separate cells and determine if 5-HT has a growth stimulatory effect on
homogeneous populations.
It is our hypothesis that 5-HT from fetal intestine is a "proliferation factor" that
supports cotyledon cell proliferation during pregnancy. It is speculated that 5-HT may
operate as a two-function "switch" for the control of two different and sequenced
physiological stages. The first stage involves sustaining pregnancy and the second stage
involves facilitating detachment of the placenta at partum. It is suspected that high
concentrations of 5-HT (50 µM) may stimulate placental cell proliferation to sustain
attachment of the placenta during pregnancy, whereas a peripartum drop in fetal blood 5HT (< 13 µM) may stimulate M:rv1P acti vity. The proposed stimulation of:Mrv1P activity
would facilitate detachment of the placenta and uterine regression. Indeed, it has been
shown that a low dose of 5-HT (5 µM) stimulates M:rv1P activity in cultured rat and
human myometrial cells and may be involved in uterine regression (Jeffrey et al., 1991).
Results of the present research support part of our hypothesis by showing that 5-HT
increased incorporation of 3H-thymidine into DNA in a dose-related manner and within a
physiological concentration range.
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PARTIV
EFFECT OF 5-HYDROXYTRYPTAMINE ON MATRIX
METALLOPROTEINASE ACTIVITY IN BOVINE PLACENTA
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INTRODUCTION
The end of pregnancy is characterized by placental detachment. The mechanism of
placental detachment is not clear but appears to involve the activation of matrix
metalloproteinases (11MPs), such as collagenase (Eiler and Hopkins, 1993; Maj and
Kankofer, 1997). Collagenase-1 (:rvfMP-1) immunoreactivity was reported in amniotic
epithelial and interstitial cells, decidual cells, and intermediate trophoblasts in thirdtrimester human placenta (Vettraino et al., 1996). Ninety-two kDa gelatinase (MMP-9)
is produced by cells of the amniochorion during labor, suggesting that proteolysis assists
in fetal membrane rupture at birth (Vadillo-Ortega et al., 1995). Furthermore, Maj and
Kankofer ( 1997) reported the presence of proteolytic activity of :rvfMP-2 and M1v1P-9 in
bovine term placenta. This information strongly supports the involvement of M1v1Ps in
placenta detachment. It is suspected that in the cow the proteolytic mechanism of
placenta detachment may be activated in a short amount of time. For example,
spontaneous expelling of placenta that is left attached in the uterus after pre-term
cesarean section in cows takes approximately 24 hours, suggesting that the system can
be activated during this time (Eiler et al. , 1997). Knowing what stimulates the release of
M1v1Ps is central to resolving the mechanism of placenta detachment.
Early in this decade, serotonin (5-hydroxytryptamine, 5-HT) present in fetal bovine
serum (FBS) was identified as an inducer and activator of collagenase in cultured
postpartum rat and human myometrial smooth muscle cells (Jeffrey et al., 1991). It was

found that 5-HT at a concentration of 5 µM maximally stimulated the myometrial cells,
and that these cells displayed an obligatory requirement for 5-HT to produce collagenase
(Jeffrey et al., 1991). Five-HT induces collagenase production in myometrial smooth
muscle cells by activating the gene for the enzyme (Wilcox et al. , 1992), and this effect is
mediated by the 5-HT2 receptor subtype (Rydelek-Fitzgerald et al., 1993). The
regulatory effect of 5-HT on collagenase is of special interest, since concentrations of 553

HT in fetal blood are extremely high (30 µM to 50 µM), dramatically drop at delivery by
cesarean section (13 µM) (Fecteau and Eiler, 1998), and stay low in the neonate (Jeffrey
et al., 1991; Fecteau and Eiler, 1998). The source of the high 5-HT concentrations is
not known, but we suspect it may be the intestine since approximately 95% of 5-HT are
located in the enterochromaffin cells in the gastrointestinal tract (Tyce, 1990). The high
fetal concentrations of 5-HT may be supporting the growth of the placenta during
gestation, since 5-HT was reported to act as a growth factor in various cell types
(Nemecek et al., 1986; Tutton et al., 1987; Seuwen and Pouyssegur, 1990), while at the
same time inhibiting :tv1}..1]) activation. We hypothesize that 5-HT from fetal intestine
acts as a "proliferation factor" to support placental cell growth during pregnancy. In our
hypothesis, partial withdrawal (by decreased secretion and/or increased inactivation) of
fetal blood 5-HT is a cause for both (1) arrest of placental cell proliferation and (2)
activation of:tv1}..1])s leading to detachment of the placenta. The objective of the current
study was to determine if 5-HT stimulates :tv1}..1]) activity in bovine placental cells in
culture, in isolated placentomes, and in the whole animal.
MATERIALS AND METHODS

Tissue Collection
Placentomes were collected from cows

?:

270 days of gestation at an abattoir.

Gestation age was determined by using a fetus development chart (Roberts, 1971). A
minimum of 8 placentomes were obtained from each of 16 cows. During collection,
placentomes were cut from the placental tissue to allow excess cotyledon to show
umbilical vessels in order to be used for catheterization and perfusion when appropriate.
Placentomes were placed in plastic bags moistened with saline and kept in a cooler filled
with ice. Placentomes were used within 24 hours once back at the laboratory.
Reagents
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Dulbecco ' s Modified Eagle Media (DMEM)/F-12 (50/50) Nutrient Mixture and
trypsin-EDT A ( 1X) solution were obtained from Fisher Scientific (Pittsburgh, PA); fetal
bovine serum (FBS), newborn bovine serum (NBS), antibiotic-antimycotic (l00X,
ABAM) solution, prepared with 10,000 units/mL penicillin G sodium, 10,000 µg/mL
streptomycin, and 25 µg/mL amphotericin B, insulin-transferrin-selenium-X (100 X,
ITS) were obtained from Gibco BRL (Grand Island , NY); epidermal growth factor (100
µg/vial, EGF) was obtained from Becton Dickinson (Bedford, MA); Hank's Buffered
Salt Solution (IO X), 5-hydroxytryptamine hydrochloride, 5-hydroxytryptamine
creatinine sulphate and Clostridium histolyticum collagenase type I were obtained from
Sigma Chemical Company (St. Louis, MO) ; fluorogenic substrate Mca-Pro-Leu-GlyLeu-Dpa-Ala-Arg-NH2 was obtained from Bachem Bioscience, Inc. (King of Prussia,
PA).
Cell Culture Preparation
Primary explants of bovine placenta were prepared in our laboratory. Once
collected, the two tissues comprising the placentome, which are the cotyledon (fetal part)
and caruncle (maternal part) were separated manually. Small pieces of each tissue were
cut using a sterile scalpel and placed in individual sterile 50 mL conical centrifuge tubes
containing DMEMIF12, 10% FBS, ABAM, EGF and ITS , and placed on ice for return
to the laboratory. Once in the laboratory, tissue pieces were finely minced, washed with
HBSS , then placed in cell-culture flasks (Primaria, 25 cm 2) with up to 5 mL of medium.
When cell outgrowths were present and at least 50% confluent, cells were harvested by
trypsinization and passed into 75 en/ flasks .

Cell Culture Experiment
The objective of this experiment was to determine if 5-HT could induce l\.1MP
activity in cultured bovine placental cells. This was accomplished by directly assessing

l\.1MP activity in culture medium of cells treated with 5-HT and cells not treated with 555

HT using a fluorometric assay for M11Ps.
Flasks were set up containing DMEM/Fl2, DMEM/Fl2 plus 10% NBS or
DMEM/Fl2 plus 10% FBS, all with and without 5-HT (5µM). Five hundred thousand
cells were plated in each flask and media samples were taken at 12, 24, and 48 hours. At
each collection time, 2.0 mL were taken from each flask and replaced with 2.0 mL fresh
media with or without 5-HT. Once collected, samples were frozen at -70°C until
analyzed using a fluorometric assay (Knight et al., 1992). Knight et al. (1992) reported
using this assay to determine activity of collagenase, stromelysin, gelatinase and a
punctuated metalloproteinase (PUMP).
Fluorometric Assay

Matrix metalloproteinase activity was extrapolated from a standard curve (Figure
4.1) that was established using bacterial collagenase from Clostridium histolyticum (type
I). Standard concentrations used were 1.25 nM, 2.5 nM, 5.0 nM, 7.5 nM, and 10 nM.
Collagenase was reconstituted in DMEM/Fl2 to the concentration of 10 nM, then the 10
nM concentration was diluted in DMEM/Fl2 to the other standard concentrations.
Standards were made fresh for each assay.
An M11P assay buffer (50 mM Tris-HCI, 0.05% Brij 35, 10 mM CaChin 1 L

distilled water, pH 7.8) and stop solution (2 .0 M sodium formate in 100 mL distilled
water, pH 3.7) were warmed to 40°C in a water bath; then 2.45 mL of assay buffer were
added to each standard and sample tube plus a tube used as a blank. Standard or sample
(25 µL) were added to respective tubes; then 25 µL fluorogenic substrate (reconstituted
in 916 µL dimethylsulfoxide) were added to all tubes. Tubes containing the solution
were vortexed, then placed in the water bath to incubate for 20 minutes at 40°C. After
incubation, the reaction was stopped with 100 µL of stop solution, tubes were vortexed
and then samples were analyzed on a recording spectrofluorophotometer (model RF-
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5000, Shimadzu Corporation, Kyoto, Japan) set at Acx328 nm, Acm393 nm. During
sample analysis, tubes were kept warm in a water bath at 40°C. The fluorescence
intensity value of the blank was subtracted from values obtained for standards and
samples.

Isolated Placentome Experiments
The objective of this experiment was to determine if 5-HT could induce M:MP
activity in isolated placentomes. M:MP activity was assessed indirectly by determining
force needed to separate the cotyledon and caruncle of the placentome, hydroxyproline
(collagen breakdown product) release, and total protein release in the fetal-maternal
interface.
Two different experiments were conducted . The objective of experiment 1, was to
determine whether 5-HT added to perfusion blood would cause detachment of cotyledon
from caruncle. In this experiment 4 different cows were used. Two placentomes were
selected from each cow. One placentome was used as control (perfused with blood
only), and one placentome was experimental (perfused with blood plus 50 µM 5-HT).
Placentomes were perfused according to a method by Eiler and Hopkins (1992) . Each
placentome was placed in a plastic chamber. The most prominent umbilical vessel
entering the placentome was catheterized with a 20-gauge 3.81-cm length venous
catheter. This was used as a blood perfusion port. The other major umbilical vessels, if
leaking, were ligated to assure a deep perfusion of the cotyledon. Blood outflow from
the capillaries was drained into the chamber that contained the placentome and then
dripped into a collection tube. Placentomes were perfused with fresh , oxygenated
bovine blood by use of an open circulation device and a gravity driven perfusion system
(blood was not recirculated). Perfusion rates varied between 2.0 cc and 5.0 cc/minute.
Bovine blood used for perfusion was collected in saline (1 /5 blood volume) and heparin
(10 units/ cc). Before use, fresh blood was oxygenated to arterial red from dark venous
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color by using a rotary evaporator under flow of oxygen, then supplemented with
dextrose (400 mg/dL) . Placentomes were moisturized with saline and covered with a
plastic sheet. The blood and placentomes were kept at 39°C during the experiment.
Placentomes were perfused for 4 hours. Blood perfusion was stopped and placentomes
remained in the incubation chamber for an additional 4 hours. Metabolic activity of
placentomes was assessed at the beginning and at the end of the 4-hour perfusion by
measuring inflow/outflow CO2 and oxygen concentrations.
The objective of experiment 2, was to determine if infusion of 5-HT in Ringer
solution would induce collagenase activity in metabolically active placentomes. Four
different cows were used in the experiment, and 8 placentomes were selected from each
cow. Four placentomes were used as control and four were experimental (injected with
5µM 5-HT). Placentomes were injected through an umbilical vessel with fluid volume
equal to 10% of the placentome weight (each placentome approximately 100 g). After
5-HT infusion, placentomes were incubated in sealed plastic containers in a stationary
water bath at 39°C for 4, 6, 8, and 11 hours . At the end of 11 hours, two selected
control placentomes, that were not part of the experiment, were perfused with
oxygenated blood. Differences in utilization of oxygen and glucose and production of
CO 2 in inflow and outflow blood indicated metabolic activity.
After incubation of both infused and perfused placentomes, a previously described
manometric technique (Eiler an Hopkins, 1992) was used to determine force needed to
separate cotyledon from caruncle. Briefly, a balloon (4 .5 cm in diameter) was inserted
between cotyledon and caruncle. The balloon was connected to both a mercury
manometer and a hand-operated air pump and was inflated until the two membranes
separated. This was the point at which the pressure was recorded. The separated
membranes of the placentome were placed in a container with 50 mL of distilled water
and shaken (30 strokes per minute) for l O minutes in a DubnoffMetabolic Shaking
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Incubator. After this, the surface fluids of membranes were gently "milked" out and
filtered through 10 cm x 10 cm three layer gauze sponges into a beaker. Membranes
were discarded and fluids were analyzed for hydroxyproline release by the method of
Kivirikko et al. (1967) . Total protein release was determined by the Kjel dahl method of
nitrogen determination as described by Branstreet ( 1965).

Experiment in Cows
The objective of this experiment was to determine if 5-HT treatment of cows could
override the retention of placenta that frequently (> 70%) results when delivery is
induced with dexamethasone (20 mg) and prostaglandin F2a (PGF 2a , 25 mg) injections.
Although the mechanisms of action of dexamethasone and PGF2a in causing retained
placenta have not been elucidated, it has been proposed that the causative factor may be
a lack of:MMP activity . This is supported by the fact that injections of bacterial
collagenase into the retained placenta via umbilical cord vessels has been highly effective
(>80%) in causing detachment of the induced retained fetal membranes.
Fourteen cows near term pregnancy(> 8 months) were purchased from a local
stockyard and induced to deliver. Twenty-four hours after dexamethasone/ PGF 2a
treatment 7 cows were injected with 5-HT-creatinine sulphate (50 µg/kg, IM) in saline.
Injections of 5-HT were given every 12 hours thereafter for a maximum of 3 days, or
until delivery, whichever came first. Seven control cows received no 5-HT injections.
The occurrence of retained placenta(~ 12 hours) was evaluated clinically.
Statistical Analysis
Statistical analysis was performed using the General Linear Models procedure in
SAS . Probability of significance was reported at P

0.05. Least Square Means were

computed and compared using least significant difference techniques.
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RESULTS
Cell Culture Experiment

Effect of FBS or NBS on MlvfP activity
Supplementation of culture medium with either 10% FBS or 10% NBS increased

(P

0 .01) l\1MP activity of medium 3.1-fold and 2.5-fold, respectively, compared to

medium alone (Table 4 .1).

Table 4.1. Pooled :MMP activity of 5-HT treated and non-treated cells grown in serumfree medium (DMEM/Fl 2) or medium supplemented with 10% NBS or 10% FBS

MMP activity (nM)

Medium
DMEM/Fl2

1.36 ± 0.71 8

DMEM/Fl2 + NBS

3 .40 ± 0.72a,b

DMEM/F12

+ FBS

4.28 ± 0.76b

a,bDifferent superscript indicates significant difference (P

0.01).

Effect of 5-HT on MlvfP activity
In serum (FBS or NBS) supplemented medium, MMP activity was decreased
between 38% and 47% in medium treated with 5-HT compared to controls, however
differences betw een control group and treated group at different incubation times were
not significant (P

0 .93) (Table 4 .2). However, w hen control groups were pooled and

5-HT groups w ere pooled there w as si gnificant (P

0 .05) inhibition ofiVlMP activity in

the 5-HT group . Mean± SEM activity of pooled control and 5-HT treated groups was
3.81 nM ± 0.59 nM and 2.05 nM ± 0.60 nM, respectively. From these results, inhibitory
effects of 5-HT may be statistically debatable. However, it is clear that 5-HT at 5 µM
was not stimulatory of MMP acti vity as reported for cultured human and rat myometrial
smooth muscle cells.
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Table 4.2. Effect of 5-HT on l\11v1P activity* of cell medium (DMEM/F12)
supplemented with 10% fetal bovine serum (FBS) or 10% newborn bovine serum (NBS)
at different times of cultured placentome cell incubation
Treatment

Protease activity (l\11v1P nM/20 minutes)
at hour
0

12

Mean

24

48

9.0 8

9.2 8

6.6x

7.oa,b

3 _5x,y,z

3 _5a,b

2.5Y,Z

DMEM/F12 + FBS
Control

3 _3a,b

5.oa,b
1. 7b

+ 5-HT

1.7b

DMEM/Fl2 + NBS
3_5a,b

Control
+ 5-HT

DMEM/Fl2 (serum-free)
Control
+5-HT

1.4b

1.6Y,Z

1.8b
1.5b

1. .,,.,b

1.2z

*Type I Clostridium histolyticum collagenase equivalent (nM/20 minutes) .
a,b,c Different superscripts indicate significant difference (P s 0.05) among time
means within a row, while same superscripts indicate no difference.
x,y,z Different superscripts indicate significant difference (P s 0.05) between mean within
mean column, while same superscript indicates no difference.
Note: when all control (6 .6, 4.1, 1.6) and all 5-HT (3 .5, 2.5, 1.2) means were pooled,
there was a significant (P s 0.05) inhibition ofl\11v1P activity by 5-HT.
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Isolated Placentome Experiments
Five-HT treatment did not affect (P

0.05) manometric pressure, hydroxyproline or

total protein within and between experiment 1 and 2. Therefore, results of experiments 1
and 2 were pooled. However, results of pooled data indicated a discrete but significant
increase (P

0.05) in the amount of hydroxyproline released from the 5-HT treated

placentomes compared to that of control placentomes (Table 4.3).

Table 4.3. Effect of 5-HT added to blood perfusion or added to Ringer infusion on

manometric pressure needed to separate cotyledon from caruncle, and fetal-maternal
interface hydroxyproline and total protein content in isolated placentomes
Treatment

Manometric pressure
(mm Hg)

Hydroxyproline

Control

118±4.3a

1.57 ± 0.47a

1.70 ± 0.14a

5-HT

116±4.za

2.06 ± o.o8b

1.61 ± 0 .09a

(µglee)

Numbers are mean± SEM for pooled blood perfusion (n
infusion (n = 4 cows) experiments.

Total protein
(g/dL)

= 4 cows) and Ringer

a,b Different superscript under same column indicates significant difference
(P 0.05). Same superscript indicates no difference. Results pooled due to no
difference (P 0.05) between blood perfusion and Ringer infusion experiments and
no difference at pre-set times within infusion experiment.

:M1v1P Activity in Cows Injected with 5-HT
There was no difference in length of retention between control cows and cows
injected with 5-HT. All cows injected with 5-HT retained their placenta between 2 days
and 9 days (Table 4.4) .

Table 4.4. Number of cows induced to deliver and injected with
saline or 5-HT prior to deli very that retained placenta

Treatment
Saline
5-HT

1
6/7
6/7

2
6/7
6/7

..,

.)

5/7
5/7

Day postpartum
4
4/7
5/7

5
4/7
5/7

6
4/7
5/7

7
3/7
5/7

8
0/7
5/7

9
0/7
3/7

Number of cows affected / total number of cows.
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DISCUSSION
The experiments performed in this study were comprehensive, in that they
accounted for the effects of 5-HT at the cellular level in vitro, isolated organ level, and at
the level of the whole animal in vivo . Among all of the systems used, there was
convincing evidence that 5-HT was not stimulatory of MMP activity, as was reported for
cultured rat and human myometrial smooth muscle cells.
Jeffrey et al. (1991) reported that 5-HT added to cultured postpartum rat
myometrial smooth muscle cells at a 5 µM concentration was maximally stimulatory of
collagenase activity. Half-maximal stimulation of these myometrial cells was reported at
2 µM. In our experiment, 5 µM 5-HT was not stimulatory ofMMP activity in cultured
bovine placentome cells. Our results displayed more of an inhibitory tendency, since the
overall mean ofMMP activity of 5-HT treated cells (2. 05 nM) was significantly lower
than the overall mean of MMP activity of control cells (3 . 81 nM).
Although there was no 5-HT stimulation of MMP activity, the amount of MMP
activity varied according to supplementation of med ium, with cells grown in medium
plus FBS responding with the highest activity, and cells grown in serum-free medium
responding with the lowest activity. Fetal bovine serum contains hormones,
polypeptides and other substances that are involved in controlling cellular processes,
such as proliferation and protein synthesis (Freshney, 1994), whereas serum-free medium
cannot support these cellular processes as effectively. The addition of 5-HT to the
medium may have slowed down cellular processes such as protein synthesis. We
analyzed the concentration of 5-HT in the commercial FBS and NBS used via an enzyme
immunoassay specific for 5-HT (not reported ). We found that FBS contained
approximately 16 µM 5-HT and NBS contained a negligible amount (0.0034 µM) of 5HT. Therefore, the cells grown in medium supplemented w ith FBS were actually
exposed to roughly 7 µM 5-HT, which did not stimulate MMP activity in our cells. Our
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decision to use 5-HT at a concentration of 5 µM was based on the positive response of
the placentome cells in proliferation assays when exposed to 5-HT at concentrations
between 2.5 µMand 25 µMin our laboratory (Fecteau and Eiler, 1998). Our decision
was supported by the work of Jeffrey et al. ( 1991 ). The discrepancy between our results
and those of Jeffrey et al. (1991) could be explained, in part, by the use of different
animal species and different types of cells (postpartum myometrial smooth muscle cells
versus prepartum placentome cells).
Isolated placentomes are an intermediate step between cell culture and intact animal
experimentation. In the isolated placentome experiments, inactivation of 5-HT by
peripheral organs (lungs, liver, and placenta) was excluded . Ringer's solution (plus 5HT) infusion and blood (plus 5-HT) perfusion techniques were used to evaluate effects
of oxygenation and blood biochemical variables introduced by whole blood use. In both
types of experiments, blood perfused or Ringer's solution infused placentomes retained
metabolic capacity for respiration by taking up oxygen and producing CO 2 and using Dglucose. The viability of excised placentomes is excellent. We were able to culture cells
from explants taken from 6 day old placentomes that were kept in ice. In the placentome
model, a physiological indicator (loosening of cotyledon from caruncle) and two
biochemical indicators hydroxyproline release (a measure of collagen hydrolysis) and
total protein release (a measure of non-specific proteolytic activity) were used . Eiler and
Hopkins (1992) reported that when the degree of collagen breakdown reached a
physiological point to separate fetal membranes from the caruncle, the force needed to
separate cotyledon from caruncle decreased significantly (about 50%). At the same time,
the amount of hydroxyproline increased 50- to 90-fold when total protein increased 4- to
6-fold. Our experiment with infused saline plus 5-HT revealed that there was no
decrease in manometric force needed to separate cotyledon from caruncle. However,
there was a minimal but significant (P<0. 05) increase in hydroxyproline (from 1.57
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µg/mL to 2.06 µg/mL), and no change in total protein compared to control. The

interpretation of results of this experiment is that there was not sufficient collagen
breakdown to cause a physiological effect. We believe that a significant difference in
hydroxyproline release was attained because of the unusually low dispersion (0.04 SEM,
0.08 SEM) recorded in the control and 5-HT groups, respectively. In this experiment, 5HT concentrations were 50 µM, which is the fetal blood maximal concentration (Jeffrey
et al., 1991) and 10 times more than the concentration used in cell culture experiments.
The results from these experiments support the results of the cell culture experiments in
that there was no stimulation ofM1v1P activity by 5-HT.
High incidence (over 70%) of placenta retention can be caused by inducing cows to
deliver with injections of dexamethasone (Thorburn et al., 1977). In our experiment, we
induced delivery by using both dexamethasone and PGF 2a injections. This combination
usually results in delivery between 60 hours and 80 hours with over 85% placenta
retention at 12 hours post delivery. This retention often lasts between 2 and 10 days
(Eiler and Hopkins, 1993 ; Eiler, 1997). The research advantage of the induced retained
placenta model versus naturally occurring placenta retention is the standardization of
experimental conditions, which is not possible with privately owned cows. The induced
model is a logical first step in this study.
The mechanism for placenta retention has been associated with lack of Mrv1P
activity at the placentome level (Eiler and Hopkins, 1993 ; Eiler, 1997; Maj and
Kankofer, 1997). In fact, infusion of collagenase via umbilical cord vessels is the most
effective treatment to detach retained placenta in cows (Eiler and Hopkins, 1993) and
mares (Haffner et al., 1998). Although the mechanism by which dexamethasone induces
placental retention is not fully understood , dexamethasone has been shown to inhibit
collagenase mRNA production (Reddy et al. , 1998), decrease levels ofM1v1Ps in oral
fibroblastic cells but not in oral epithelial cell lines (K ylmaniemi et al. , 1996), and reduce
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fibronectin and collagen III synthesis in amnion cells that may be associated with
prematurely ruptured membranes (Guller et al., 1995).
Injections of PGF2cx can also cause delivery and high incidence ofretained placenta
(Thorburn et al., 1977). Interestingly, both glucocorticoids and PGF2cx are elevated
during spontaneous delivery in the cow, and it was reported that dexamethasone has a
stimulatory effect on PGF 2cx secretion by the placentome (Thorburn et al., 1977). If
dexamethasone is indeed an inhibitor of :MlvIPs, it is logical to assume that overriding
dexamethasone inhibition of placental l\.1MP activity may prevent retention. Five-HT is a
substance that has the ability to stimulate Mlv1Ps. This stimulation potential is supported
by two different experiments: (1) Jeffrey et al. (1991) reported 5-HT markedly
stimulated secretion of collagenase by myometrial smooth muscle cells; (2) Zaiem et al.
(1994) reported that intramuscular (IM) injection of Sergotonine (Rhone-Merieux, Lyon,
France) within 12 hours postpartum decreased retention of placenta from 38% to 10% in
cows. Sergotonine is a combination of 5-HT creatinine sulfate and ergometrine
(uterokinetic substance). It is suspected that the positive effect in preventing placenta
retention was due to 5-HT since uterokinetic substances have been reported as
ineffective in preventing primary retained placenta in cow (Stevens and Dinsmore, 1997).
In our experiment with cows, we injected 5-HT every 12 hours until delivery starting 24
hours after dexamethasone-PGF 2cx injections. The dose of 5-HT used was roughly the
same as that used by Zaiem et al. (1994) to decrease incidence of retention from 38% to
I 0%. It is observed in the work of Zaiem et al. ( 1994) that 10% retention in the treated
group is still high since in this country the average incidence is about 7% (in untreated
cows). However, our treatment was ineffective since 6 of 7 cows treated with 5-HT had
retained placentas. Five-HT did not override the mechanism responsible for placenta
retention. This result indirectly suggests that 5-HT did not promote :Mlv1P activity. In
conclusion, our results indicate that 5-HT did not override dexamethasone-PGF2cx
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induced retention. Based on our results we do not see the practical potential of 5-HT
injections to prevent retention in situations when early delivery is indicated. The results
are consistent with the cell culture experimental results and placentome experimental
results. We realize that our experimental conditions are not similar to spontaneous
delivery. However, the lack ofM:MP stimulation by 5-HT indirectly supports our
hypothesis of a withdrawal of 5-HT causing activation of MMPs.
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PARTV
LOCALIZATION OF COLLAGENASE AND
5-HYDROXYTRYPTAMINE IN BOVINE PLACENTA
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INTRODUCTION
Five-HT has been localized by immunocytochemistry in endothelial cells of human
umbilical vessels (Sexton et al., 1996). More recently, Huang et al. (1998) utilized both
light and electron microscopy techniques to localize 5-HT and its receptor in numerous
cell types of the human placenta. Also, Yavarone et al. (1993) localized 5-HT in the
ectoplacental cone and in nuclear chromatin-like material of giant cells in the mouse
placenta. The appearance of 5-HT in the placenta and across species suggests that the
placenta may be a target organ for 5-HT. Likewise, 5-HT may play a role in placental
development (Huang et al. , 1998) and regulate cellular functions such as proliferation,
differentiation or secretion (Yavarone et al. , 1993). Furthermore, there is evidence that a
5-HT transporter exists in the human placenta supporting the potential role of 5-HT in
placental function (Balkovetz et al. , 1989). It is interesting to note that the source of 5HT in the placenta is not known . It is suspected the source may be the intestine, since
the majority of body 5-HT is located in the enterochromaffin cells of the gastrointestinal
tract (Tyce, 1990).
In addition to localization of 5-HT in the placenta, 5-HT in fetal bovine serum has
been reported at concentrations of30 µM to 50 µM (Jeffrey et al., 1991 ; Fecteau and
Eiler, 1997), while newborn bovine serum 5-HT concentrations range from~ 1 µM
(Jeffrey et al. , 1991) to 24 µM (Fecteau and E iler, 1997). It was found that a 5-HT
concentration of 5 µM maximally induced collagenase in certain cultured cells, whereas
higher concentrations caused no further increase in collagenase production (Jeffrey et al.,
1991). We hypothesize that the high 5-HT concentrations may originate from the bovine
fetal intestine and act as a " proliferation factor" to support placental cell growth during
pregnancy. Partial withdrawal (by decreased secretion and/or increased inactivation) of
fetal blood 5-HT may be a cause for both : (I) arrest of placental cell proliferation, and
(2) activation of matrix metalloproteinases (MMPs) . Activation of MMPs and arrest of
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cell proliferation would lead to postpartum placenta detachment. It is important to
investigate the location of 5-HT in placental tissues to further elucidate mechanisms of
action of 5-HT. The objectives of the present study were to investigate the presence of
5-HT and collagenase in bovine placental tissues using light microscopy and electron
microscopy techniques.

MATERIALS AND METHODS
Collection of Placentomes
Placentomes were obtained from Brown Packing Company, Gaffney, SC.
Cotyledon and caruncle samples were taken from placentomes of cows during mid
gestation (180 days to 240 days) and late gestation(:::: 270 days). Gestation age of fetus
was approximated using a fetus development chart (Roberts, 1971 ). Samples were
collected within 30 minutes and processed immediately upon collection for light
microscopy study. Postpartum cotyledons (fetal membranes) were collected from cows
after natural delivery at The University of Tennessee Dairy Farm. Cotyledons were
obtained anywhere from 30 minutes to 4 hours after delivery of calf while membranes
were still hanging from the cow. Hanging membranes undergoing detachment were cut
with scissors, placed in a plastic bag and put on ice until return to the laboratory. In the
laboratory, debris was removed from cotyledons by rinsing the membranes with
physiological saline. The samples were then processed for light and electron microscopy
study.
Collection oflntestine and Uterus
Tissues from the uterus and intestine were obtained from female Sprague Dawley
rats 2 days after they had given birth to a litter of pups. Intestine was used as a positive
control for 5-HT localization and uterus (myometrium) was used as a positive control for
collagenase localization. Rats were euthanized in a CO 2 chamber and intestine and
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uterus were removed from each rat. Tissues were rinsed with physiological saline and
processed for light and electron microscopy.
Preparation of Tissue Sections

Light Microscopy
Immediately upon collection, placentome tissues were separated and pieces
(approximately 0.5 cm2) of cotyledon and caruncle were cut using a single-edged razor
blade. Intestine and uterus were cut using a single-edged razor blade. Pieces of
cotyledon villi, caruncle (crypt region), intestine and uterus were placed in separate 50

mL conical tubes containing either Bou in fixative or 10% buffered formalin. Tissue
pieces were fixed for 4 hours in Bouin fixati ve and for 24 hours in formalin then placed
in 70% ethyl alcohol. Postpartum cotyledons were processed the same way as
prepartum tissues. Alcohol of Bou in fixed tissues was changed twice a day in order to
remove yellow pigment. Tissues were then embedded in paraffin (low melting point
Paraplast, Fisher Scientific) using an automated processor (TissueTek VIP, Ames
Division, Miles Laboratories, Inc.) (Appendix).
Tissue sections (5 µm) were cut on a microtome, placed in 20% alcohol to help
reduce wrinkling of section then floated on warm water (40°C) and placed on a charged
slide (Superfrost/Plus, Fisher Scientific). Slides were dried using a slide warmer.
Tissue sections were then processed to localize collagenase or 5-HT by the modified
method of Lui and Godkin (1992) (Appendix).
Pieces of cotyledon and caruncle tissues and rat uterus were frozen for enzyme
(collagenase) immunolocalization based on a method by D r. Antonin Bukovsky
(Department of Obstetrics and Gynecology, The University of Tennessee Medical
Center; personal communication) (Appendix).
Tissue sections (5 µm) were cut on a cryostat (Reichert-Jung 2800 Frigocut) and
placed directly on a charged microscope slide. Slides were stored at -70°C until used .
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Tissue sections were then processed to localize collagenase (Appendix).
Electron Microscopy

Postpartum cotyledon villi were fixed in 2.5% glutaraldehyde/cacodylate buffer
solution for 4 hours then placed in cacodylate buffer with 7.5% sucrose until further
processing. Tissues were embedded in plastic (Appendix) .
Technical services were utilized from the Electron Microscopy Laboratory, The
University of Tennessee, Knoxville for cutting the plastic blocks and placing the cut
tissues on nickel grids. Once grids were prepared, tissues were stained with saturated
uranyl acetate and lead citrate (Appendix), then immunolabeled for 5-HT or collagenase
(Appendix).
Specimens were examined on a Philips 201 transmission electron microscope and
micrographs were made of cotyledon villi connective tissue. Negatives were exposed
and 8 x 10 prints on polycontrast paper (Eastman Kodak Company, Rochester, NY)
were developed. To develop the micrographs, the prints were placed in Dektol ·
developer and stop bath (Eastman Kodak Company) for approximately 1.5 minutes and
30 seconds, respectively. Prints were then placed in Rapid Fixer (Eastman Kodak
Company) for 2-3 minutes, rinsed in running water for 3 minutes and placed on a rack to
dry.
RESULTS

Light Microscopy
Attempts (frozen tissues and paraffin-embedded tissues) to localize collagenase in
bovine placenta and rat uterus were unsuccessful.
Results of the immunohistochemical staining of 5-HT are shown in Figure 5.1.
Results reveal 5-HT positive areas as brown and 5-HT negative areas as blue or pink.
The negative controls showed negative reactions.
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Figure 5.1. Immunohistochemical localization of 5-HT in bovine placenta. (A) Mid-

term caruncle negative control. (Al) Mid-term caruncle showed diffuse 5-HT
immunoreactivity. (B) Full-term cotyledon negative control. (B 1) Full-term cotyledon
showed 5-HT immunoreactivity on surface membrane of cells. Nuclei and cytoplasm
immunonegative for 5-HT. (C) Negative control. Villi of full-term cotyledon. (Cl)
Tip of cotyledonary villus. (D) Villi of full-term cotyledon showed discrete
immunoreactivity in connective tissue and (inset) on surface membrane of epithelial cells.
(E) Blood vessel in full-term cotyledon negative control. (F) Endothelium of blood
vessel showed 5-HT immunoreactivity. Bar= 200 µm (A, Al, C); 5 µm (B, Bl, Cl);
102 µm (D); 61 ~Lm (D 1); 25 µm (E and F); 49 µm (inset : F).
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Figure 5.1 (continued). (G) Postpartum cotyledon negative control; (inset) connective
tissue. (H) Postpartum cotyledon showed 5-HT immunoreactivity on surface epithelial
cells and cytoplasm. Diffuse 5-HT immunoreactivity in connective tissue (inset),
however, isolated cells in connective tissue appear 5-HT immunonegative. (I) Rat
intestine negative control. (J) Isolated cells in rat intestine immunoreactive to 5-HT.
Bar= 100 µm (G and H) ; 25 µm (I and J) ; 42 µm (inset: G and H).
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Surface membranes of epithelial cells of mid and full gestation cotyledon and
caruncle were immunoreactive to 5-HT. Connective tissue of prepartum and postpartum
placenta exhibited diffuse 5-HT immunoreactivity, however cells within connective tissue
were immunonegative. Five-HT immunoreactivity was also seen in endothelium lining
blood vessels of mid and full gestation and postpartum placenta. The cytoplasm of most
lining epithelial cells of villi in the postpartum placenta were immunoreactive to 5-HT,
however, cytoplasm of underlying cells was immunonegative. Isolated cells in the lamina
propria-submucosa in rat intestine positive control tissue were immunoreactive to 5-HT.
Electron Microscopy
Attempts to localize collagenase were unsuccessful. Results of electron microscopy
localization of 5-HT are shown in Figure 5.2. Five-HT positive areas are indicated by
the round black ( colloidal gold) particles, which are in close proximity to collagen fibers.
Five-HT negative areas show no gold particles (Figure 5.3).

DISCUSSION
Attempts to localize collagenase in the bovine placenta were unsuccessful. The
collagenase antibody was species specific for bovine and possibly rat tissues and was
specific for the 57- and 53-k.Da forms of the proenzyme and 47- and 43-kDa form of the
active enzyme. A reasonable explanation for lack of collagenase immunoreactivity in
bovine and rat tissues may be that these tissues do not have the kDa forms of collagenase
that cross-react with the antibody. This is supported by negative results (not shown)
from Western blots performed in our laboratory in which lysates from placental cells
were tested for cross-reactivity with the collagenase antibody.
Attempts to localize 5-HT in both the fetal (cotyledon) and maternal (caruncle)
tissues of the bovine placenta and in the postpartum fetal tissue were successful.
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Figure 5.2. Postpartum cotyledon tissue. Colloidal gold particles (arrow) indicating
presence of 5-HT are located on or near collagen fibers (CF). Bar= 0.158 µm.
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Figure 5.3. Postpartum cotyledon tissue. Negative for 5-HT,
collagen fibers (CF) visible. Bar= 0.158 µm.
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Positive staining for 5-HT was seen on the surface membranes of epithelial cells, in
connective tissue and in blood vessels. Immunoreactivity of 5-HT in connective tissue
was identified in postpartum cotyledon by both light microscopic methods and electron
microscopic methods. For the latter, we used colloidal gold to localize 5-HT that was
aligned either next to or on collagen fibers . The purpose of this alignment is not known.
Kishi and Hayakawa (1989) reported localization of immunoreactive collagenase
inhibitor protein along collagen fibers of bovine aortic medial tissue, suggesting that
collagenase and its inhibitor could participate in control of collagen catabolism in bovine
aorta. It is suspected that 5-HT is also involved in collagen catabolism. Passaretti et al.
(1996) reported that 5-HT decreased the gene expression for collagen type I and III and
fibronectin in rat uterine smooth muscle cells. In the placenta, it is expected that 5-HT
would initiate its effect on collagen and/or collagenase at cell surface not directly on the
collagen fiber. It is hypothesized that once collagen fibers are degraded, 5-HT may be
released from the fiber to regulate collagen synthesis. This assumes that 5-HT is bound
to collagen fibers, which is not known. At this time, there is no logical explanation for
the alignment of 5-HT on the collagen fibers .
There appeared to be no change in 5-HT immunoreactivity from placentas during
pregnancy to postpartum cotyledon, except surface epithelial cells on villi appeared to
have 5-HT in their cytoplasm. It is interesting that cells underlying these epithelial cells
did not appear to have 5-HT in their cytoplasm. One should keep in mind that technical
artifact could have been introduced in the sampling of postpartum cotyledons, since the
normal expelling of membranes often takes between 1 to 4 hours after calf s delivery.
When possible, we tried to minimize time by cutting membranes close to the vulva
instead of waiting for membranes to be expelled. Although viability of postmortem and
excised placentomes is excellent, cell deterioration is expected .
Based on our hypothesis, it was thought that there could be weaker staining of 5-HT
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in the postpartum cotyledon than in placenta during pregnancy. It appeared that this was
not the case, however results are based on what can be seen, not quantitated. Based on
other experiments that we performed using enzyme immunoassays for 5-HT,
concentrations of 5-HT in fetal serum and tissues were significantly higher during
pregnancy than during delivery or in neonatal calves (Fecteau and Eiler, 1998). In
addition, MAO activity was reported to increase in human placenta at the time of
delivery (Kirkel et al., 1992). Whether or not MAO activity increases in bovine placenta
at delivery time is not known.
Sexton et al. (1996) reported that endothelial cells of human umbilical vessels are
capable of synthesizing 5-HT. Immunoreactivity of 5-HT was observed in umbilical
artery and vein from late pregnancy but not early pregnancy (Sexton et al., 1996),
however, it is not known if endothelium of placental vessels synthesize 5-HT. Since 5HT immunoreactivity was observed in blood vessel endothelium of mid- and fullgestation placentae and in postpartum cotyledon, it may be that 5-HT travels through the
blood to the placentome and is not actually synthesized in the placentome.
To our knowledge, this is the first work in which 5-HT has been localized in the
bovine placenta. It is unknown if 5-HT is synthesized by placental cells. We did not
identify 5-HT in the cytoplasm of cells, which may suggest that 5-HT is not synthesized
or stored in the cells. Furthermore, there was positive staining for 5-HT in the
endothelium of blood vessels which may indicate that 5-HT has been transferred through
the blood if it is indeed not synthesized in the endothelial cells.

82

APPENDIX
Procedure for Embedding Tissue with Paraffin
80% ETOH for 2 hours
95% ETOH for 1. 5 hours
95% ETOH for 1.5 hours
100% ETOH for 1 hour
100% ETOH for 1. 5 hours
100% ETOH for 1.5 hours
50% ETOH/50% xylene for 1.5 hours
50% ETOH/50% xylene for 1 hour
100% xylene for 1 hour
100% xylene for 1 hour
Paraffin for 2 hours at 50°C
Paraffin for 2 hours at 50°C

Procedure to Localize Collagenase or 5-HT
1.

Deparaffinize and rehydrate by series of xylene and graded alcohol changes.

2.

Place in Phosphate buffered saline (PBS) for 5 minutes.

3.

Quench endogenous peroxidase activity by addition of 3% hydrogen peroxide
in 100% methanol and incubate for 20 minutes at room temperature (all
incubations were in a humidified chamber).

4.

Wash in PBS for 5 minutes .

5.

Add 1% ammonium chloride (NH 4 Cl) in PBS to slides and incubate for 20
minutes at room temperature.

6.

Wash in PBS for 5 minutes .

7.

Block nonspecific proteins with Power Block (BioGenex, San Ramon, CA) and
incubate for 10 minutes at room temperature.
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8.

Rinse with PBS.

9.

Add primary antibody rabbit anti-serotonin (Sigma, St. Louis, MO), mouse
anti-rabbit collagenase (Developmental Studies Hybridoma Bank, University of
Iowa) or negative control serum (rabbit serum or mouse serum) and incubate
overnight at 4°C.

10. Wash slides 5 times for 5 minutes each with PBS.
11 . Add secondary antibody (immunoglobulins for rabbit or mouse produced in
goat) and incubate for 20 minutes at room temperature.
12. Wash as in step 10.
13 . Add peroxidase-conjugated streptavidin and incubate for 20 minutes at room
temperature.
14. Wash as in step 10.
15 . Add chromogen diaminobenzidine/H20 2 (DAB) - prepare by adding 0.5 mL
buffer to 4. 5 mL distilled water, then add 4 drops of chromogen and mix well,
then add 2 drops of hydrogen peroxide substrate and mix well.
16. Incubate at room temperature until color change seen (brown color) then rinse
with PBS and tap water.
17. Add hematoxylin for 2 minutes at room temperature then rinse with tap water.
18. Dehydrate sections by processing through graded alcohol and xylene changes in
reverse order of rehydrating procedure.
19. Mount coverslips with permount.
20. View and take pictures of slides using an Olympus microscope (Southern Micro
Instruments, Inc., Atlanta, GA) and attached Olympus camera.
Freezing Tissues for Jmmunolocalization of Collagenase
1. Place enough tissue-freezing medium into plastic mold to cover bottom of
mold.
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2.

Place tissue-piece in mold and cover tissue with freezing medium so that
medium slightly exceeds mold .

3.

Fill a glass Petri dish with liquid nitrogen (LN2) and wait for boiling ofLN2 to
stop.

4.

Float mold with embedded tissue on the LN2 in Petri dish. Do not let LN2
make contact with medium in mold.

5.

Freezing medium in mold becomes "milky" in color and the round "eye" closes
toward the center.

6.

When "eye" almost closed remove mold from Petri dish.

7. Place molds in freezer bags and store at -70°C.
Immunolocalization of Collagenase in Frozen Tissue

1.

Fix tissue in acetone for 5 minutes.

2.

Wash in PBS for 5 minutes.

3.

Quench endogenous peroxidase activity by addition of 3% hydrogen peroxide
in 100% methanol and incubate for 20 minutes at room temperature (all
incubations were .in a humidified chamber).

4.

Wash in PBS for 5 minutes.

5.

Add primary antibody mouse anti-rabbit collagenase undiluted or diluted 1: 100
or normal mouse serum for control for 20 minutes.

6.

Wash in PBS 5 times for 5 minutes.

7.

Add secondary antibody (immunoglobulins for mouse produced in goat) and
incubate for 20 minutes at room temperature.

8.

Wash as in step 6.

9.

Add peroxidase-conjugated streptavidin and incubate for 20 minutes at room
temperature.

10. Wash as in step 6.
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11. Add chromogen DAB - prepare by adding 0.5 mL buffer to 4.5 mL distilled
water, then add 4 drops of chromogen and mix well, then add 2 drops of
hydrogen peroxide substrate and mix well.
12. Incubate at room temperature until color change seen (brown color) then rinse
with PBS and tap water.
13. Add hematoxylin for 2 minutes at room temperature then rinse with tap water.
14. Dehydrate sections by processing through graded alcohol and xylene changes
15. Mount coverslips with permount.
Embedding Tissue in Plastic for Electron Microscopy Study

1.

Wash 3 times for 10 minutes each in distilled water.

2.

Post-fix in 1% osmium tetroxide for 1-1.5 hours.

1.

Wash as in step 1.

2.

Place in 70% ETOH for 10 minutes.

3.

Place in 80% ETOH for 10 minutes.

4.

Place in 90% ETOH for 10 minutes.

5.

Place in 100% ETOH for 10 minutes with 2 changes.

6.

Place in propylene oxide for 10 minutes with 2 changes.

7.

Place in 1 part plastic and 2 parts propylene oxide for 60 minutes.

8.

Place in 2 parts plastic and 1 part propylene oxide overnight.

9.

Remove, drain, and dry for 20 minutes.

10. Add plastic for 6-8 hours.
11 . Embed tissues in molds and incubate for 48 hours at 45°C.
12. Remove from incubator and store for later study.
Procedure for Staining Grids with Uranyl Acetate and Lead Citrate

1.

Place grids shiny side up on water droplets in a Petri dish for 5 minutes.
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2.

Blot shiny side on filter paper and transfer grids to drops of saturated uranyl
acetate for 15 minutes.

3.

Blot and rinse on a water drop.

4.

Repeat step 2.

5.

Put grids shiny side up on drops oflead citrate in Petri dish containing NaOH
chips for 5 minutes. Put cover on Petri dish. Note: wear mask, otherwise CO2
will form lead carbonate.

6.

Repeat steps 3 and 4.

7.

Blot dry and store in gelatin capsule.

Immunolabeling of Grids

Day 1
1. Place grids in filtered water drops on parafilm for 5 minutes.
2.

Remove with inverted forceps and blot shiny side on filter paper.

3.

Place grids for 20 minutes on drops of saturated sodium meta-periodate.

4.

Transfer grids to water drop for 5 minutes.

5. Place grids into 96-well plate with dilution/washing buffer* for 10 minutes with
2 changes.

6.

Add antibody to 96-well plate. Serotonin and collagenase antibodies diluted
1:50 with dilution/washing buffer. Cover plate with parafilm and place in
humidified tray on shaker.

*Combine PBS ( 15 mL), NaCl (438 mg) and gelatin ( 15 mg) then dissolve and add
bovine serum albumen (75 mg) and 1 drop of tween-20.
Day2
1.

Rinse grids twice for 10 minutes with buffer.

2.

Add protein A labeled gold (Auroprobe EM protein AG 10, Amersham
Corporation, Arlington Heights, IL) diluted 1:50 with buffer. Incubate as in
step 6.
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Day3
1.

Rinse grids twice for 10 minutes in buffer.

2.

Rinse twice for 10 minutes in PBS.

3.

Rinse twice for 10 minutes in distilled water.

4.

Fix in 2.5% glutaraldehyde/cacodylate buffer for 5 minutes.

5.

Rinse twice in buffer for 10 minutes.

6.

Rinse twice for 10 minutes in distilled water.

7.

Blot dry on filter paper and place in capsule.
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PART VI
GENERAL DISCUSSION AND CONCLUSIONS
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SUMMARY
The end of pregnancy is characterized by placenta detachment. The mechanism of
placenta detachment is not clear, but appears to involve the activation of M11Ps such as
collagenase (Eiler and Hopkins, 1992; Maj and Kankofer, 1997). A substance that has
the distinct ability to induce collagenase in postpartum cultured rat and human
myometrial smooth muscle cells is 5-HT. The concentration of 5-HT in fetal bovine
serum (FBS) was reported to be 30- to SO-fold higher than in newborn bovine serum
(NBS) and cow serum (Jeffrey et al. , 1991 ), however the purpose of such high fetal
blood concentrations is not known . It has been suggested that 5-HT may be involved in
fetal and/or placental growth (Balkovetz et al. , 1989; Yavarone et al. , 1993 ; Huang et
al., 1998). Growth stimulatory effects of 5-HT were reported for various cell types
(Nemecek et al., 1986; Seuwen and Pouyssegur, 1990), however its effect on placental
cells is not known. Huang et al. (1998) localized 5-HT and its receptor in the human
placenta but the source of 5-HT in the placenta was not clear. Yavarone et al. (1993)
reported transplacental transfer of 5-HT from the mother to the fetus in the mouse.
However, Prasad et al. (1996) stated that maternal 5-HT does not reach the fetal
circulation in the later stages of pregnancy. The gastrointestinal tract may be the source
for placental 5-HT, since approximately 95% of 5-HT found in the body is located in the
enterochromaffin cells of the tract (Tyce, 1990), and these cells develop in the fetus as
early as 8 weeks of gestation for the human (Facer et al. , 1989) and 12 weeks in the
bovine (Totzauer, 1991 ). Moreover, blood concentration of 5-HT decreases after
intestinal resection . Therefore, we hypothesize that 5-HT from the bovine fetal intestine
may act as a " proliferation factor" to support placental cell growth during pregnancy.
Partial withdrawal (by decreased secretion and/or increased inactivation) of fetal blood
5-HT may be a cause for both (1) arrest of placental cell proliferation, and (2) activation
ofM11Ps. Activation of M1v1P s may contribute to uterine regression and placenta
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detachment at partum.
The general objective of this study was to test selected aspects of our hypothesis.
The specific objectives of this study were to :
I) Determine the concentration profile of 5-HT in the intestine, placenta, muscle
and blood of bovine fetuses at mid and full gestation and at delivery, and in
newborn calves up to 72 hours old;
2)

Assess growth stimulatory effect of 5-HT on bovine placental cells by direct cell
counts, incorporation of 3H-thymidine into DNA, and a tetrazolium-based
colorimetric proliferation assay;

3)

Determine effect of 5-HT on M11P activity in bovine placental cells in culture,
in isolated placentomes, and in the whole animal;

4) Localize 5-HT and collagenase in bovine placenta.
The concentration profile of 5-HT in blood showed high concentrations in the fetus
during gestation with a dramatic decrease in concentration during delivery and staying
low in the neonate. Tissue concentrations of 5-HT followed a pattern similar to blood
with the following exceptions: intestinal 5-HT was high in the 72 hour old fetus, and
muscle 5-HT was low in the mid-gestation fetus. These results indicate that there is a
pattern of 5-HT concentration change in the fetus and newborn calf
Results of the proliferation assays diverged . When cells were treated with 5-HT,
there was an increase in incorporation of 3H-thymidine into DNA of the cells. However,
there was no effect on direct cell count, and there was an inhibitory effect when tested in
the tetrazolium-based proliferation assay. Conversion of tetrazolium to a colored
formazan product is presumed accomplished by NADPH or NADH produced by
dehydrogenase enzymes in metabolically active cells. Since addition of 5-HT decreased
the amount of colored product formed in a dose-dependent manner, then it is suggested
that 5-HT may be inhibitory of certain cellular metabolic pathways. The possibility of
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metabolic inhibition by 5-HT is supported by the results of the M:MP activity
experiments.
There was no observed stimulation ofM:MPs in isolated placentomes when either
infused or perfused with 5-HT, and there was no stimulation ofM:MPs in cows with
induced retained placenta when injected with 5-HT. Perhaps 5-HT down-regulates
genes that control M:MP production or re-directs enzymes or other substances needed
for the production of these proteases. However, Passaretti et al. (1996) reported that 5HT up-regulates the interstitial collagenase gene and down-regulates the gene for type I
collagen and other extracellular matrix proteins in rat uterine smooth muscle cells. Since
the cells and species used in our experiments and those of Passaretti et al. (1996) are
different, it is a possibility that they may respond differently to 5-HT.
There is no doubt that 5-HT exists in the placenta. Concentrations of 5-HT in the
placenta were determined in humans over 30 years ago (Garattini and Valzelli, 1965).
Recently, 5-HT was localized in human placenta (Huang et al., 1998), and now has been
localized in bovine placenta (this work). There appear to be no marked changes in
location of 5-HT in early or late gestation cotyledon and caruncle or in postpartum
cotyledon. However, apparently there was 5-HT cytoplasmic staining insurface
epithelial cells of postpartum cotyledon. It is possible that the cytoplasmic staining, in
part, may be an artifact of tissue collection due to the time that it takes the cow to expel
the placenta. In human placenta, Huang et al. (1998) located 5-HT in the cytoplasm of
cells, however this was accomplished in early and late gestation placenta not postpartum
placenta. The immunoreactivity of 5-HT in vessel endothelium of all of the stages of
bovine placenta studied supports, along with no cytoplasmic immunoreactivity, that 5HT is probably not produced in the placenta but instead is produced elsewhere and
travels through the blood to the placenta. Lack of collagenase immunolocalization in the
placenta was probably the result of inadequate antibody for the M:MPs in the tissue.
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The conclusions of this research are: (1) there is a pattern in 5-HT concentration in
fetal and neonatal blood and tissues; (2) 5-HT may be a proliferation factor for bovine
placental cells; (3) 5-HT does not stimulate N1MP activity in bovine placental tissues; and
( 4) 5-HT is visually present in the bovine placenta during pregnancy and postpartum.
These conclusions support our general hypothesis . However, many aspects of the
hypothesis have yet to be worked out. The physiological effect of 5-HT during
pregnancy and postpartum has yet to be determined, but the results of this work
combined with the supporting literature suggest that 5-HT has a definite role(s) during
pregnancy and postpartum. It is hoped that there will be continued as well as new
interest in this subject.
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